UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2022~~March 31, 2023

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36473

Trinseo PLC

(Exact name of registrant as specified in its charter)

Ireland

N/A

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

440 East Swedesford Road

Suite 301

Wayne, PA 19087

(Address of Principal Executive Offices)

(610) 240-3200

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.




Large accelerated filer	☒	Accelerated filer	◻

Non-accelerated filer	◻	Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading symbol	Name of Exchange on which registered
Ordinary Shares, par value $0.01 per share	TSE	New York Stock Exchange

As of ~~October~~April 28, ~~2022,~~2023, there were ~~34,973,747~~35,146,342 of the registrant’s ordinary shares outstanding.

Table of Contents

TABLE OF CONTENTS

`
		Page

Part I	Financial Information

Item 1.	Financial Statements	4

	Condensed Consolidated Balance Sheets as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 (Unaudited)	4

	Condensed Consolidated Statements of Operations for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ (Unaudited)	5

	Condensed Consolidated Statements of Comprehensive Income (Loss) for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ (Unaudited)	6

	Condensed Consolidated Statements of Shareholders’ Equity for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ (Unaudited)	7

	Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ (Unaudited)	98

	Notes to Condensed Consolidated Financial Statements (Unaudited)	109

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3331

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	4842

Item 4.	Controls and Procedures	4842

Part II	Other Information

Item 1.	Legal Proceedings	4942

Item 1A.	Risk Factors	4943

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5043

Item 3.	Defaults Upon Senior Securities	5143

Item 4.	Mine Safety Disclosures	5143

Item 5.	Other Information	5143

Item 6.	Exhibits	5144

Exhibit Index

Signatures

Table of Contents

Trinseo PLC

Quarterly Report on Form 10-Q

For the quarterly period ended ~~September 30, 2022~~March 31, 2023

Unless otherwise indicated or required by context, as used in this Quarterly Report on Form 10-Q (“Quarterly Report”), the term “Trinseo” refers to Trinseo PLC (NYSE: TSE), a public limited company existing under the laws of Ireland, and not its subsidiaries. The terms “Company,” “we,” “us” and “our” refer to Trinseo and its consolidated subsidiaries, taken as a consolidated entity. Trinseo PLC is the surviving entity of a cross-border merger with our predecessor company, Trinseo S.A., which merger was ~~approved by shareholders in June 2021 and~~ completed in October 2021. All financial data provided in this Quarterly Report is the financial data of Trinseo PLC, unless otherwise indicated. Prior to the formation of the Company, our business was wholly owned by The Dow Chemical Company (together with other affiliates, “Dow”). The Company may distribute cash to shareholders under Irish law via dividends or distributions made out of distributable profits.

Definitions of capitalized terms not defined herein appear within our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 (“Annual Report”) filed with the Securities and Exchange Commission (“SEC”) on February ~~23, 2022.~~27, 2023.

Cautionary Note on Forward-Looking Statements

This Quarterly Report contains, without limitation, statements concerning plans, objectives, goals, projections, forecasts, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “anticipate,” “believe,” “intend,” “forecast,” ”estimate,” “see,” “outlook,” “will,” “may,” “might,” “potential,” “likely,” “target,” “plan,” “contemplate,” “seek,” “attempt,” “should,” “could,” “would,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict.

Specific factors that may cause future results to differ from those expressed by the forward-looking statements, or otherwise impact performance or other predictions of future actions have, in many but not all cases, been identified in connection with specific forward-looking statements. Factors that might cause such a difference include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; ~~our ability to integrate acquired businesses; global supply chain volatility,~~ increased costs or disruption in the supply of raw materials; increased energy costs; our ability to successfully generate cost savings and increase profitability through asset restructuring initiatives; compliance with laws and regulations impacting our business; conditions in the global economy and capital markets; our ability to successfully investigate and remediate chemical releases on or from our sites, make related capital expenditures, reimburse third-party cleanup costs or ~~costs for transportation of our products; the outcome of the European Commission request for information; the nature of investment opportunities presented to the Company from time to time;~~settle potential regulatory penalties or other claims; and those discussed in our Annual Report filed with the SEC on February ~~23, 2022~~27, 2023 under Part I, Item IA— “Risk Factors,” within this Quarterly Report and in other filings and furnishings made by the Company with the SEC from time to time.

As a result of these or other factors, our actual results, performance or achievements may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Therefore, we caution you against relying on these forward-looking statements. The forward-looking statements included in this Quarterly Report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Available Information

Our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, are available free of charge through the Investor Relations section of our website, www.trinseo.com, as soon as reasonably practicable after the reports are electronically filed or furnished with the SEC. We provide this website and information contained in or connected to it for informational purposes only. That information is not a part of this Quarterly Report.

Table of Contents

PART I —FINANCIAL INFORMATION

Item 1. Financial Statements

TRINSEO PLC

Condensed Consolidated Balance Sheets

(In millions, except per share data)

(Unaudited)


	September 30,		December 31,		March 31,		December 31,
	2022		2021		2023		2022
Assets
Current assets
Cash and cash equivalents	$	242.8	$	573.0	$	217.1	$	211.7
Accounts receivable, net of allowance for doubtful accounts (September 30, 2022: $6.0; December 31, 2021: $4.1)		673.7		740.2
Accounts receivable, net of allowance for doubtful accounts (March 31, 2023: $6.9; December 31, 2022: $7.3)						622.5		586.0
Inventories		614.0		621.0		502.6		553.6
Other current assets		40.5		44.3		34.1		39.4
Total current assets		1,571.0		1,978.5		1,376.3		1,390.7
Investments in unconsolidated affiliates		269.2		247.8		252.7		255.1
Property, plant and equipment, net of accumulated depreciation (September 30, 2022: $579.3; December 31, 2021: $556.5)		638.3		719.0
Property, plant and equipment, net of accumulated depreciation (March 31, 2023: $708.4; December 31, 2022: $668.8)						681.0		691.1
Other assets
Goodwill		691.9		710.1		414.2		410.4
Other intangible assets, net		764.7		823.8		759.4		772.0
Right-of-use assets - operating, net		74.8		85.3		73.0		76.1
Deferred income tax assets		62.6		77.6		114.2		97.3
Deferred charges and other assets		59.4		70.1		70.7		67.5
Total other assets		1,653.4		1,766.9		1,431.5		1,423.3
Total assets	$	4,131.9	$	4,712.2	$	3,741.5	$	3,760.2
Liabilities and shareholders’ equity
Current liabilities
Short-term borrowings and current portion of long-term debt	$	16.7	$	18.5	$	16.6	$	16.0
Accounts payable		442.2		590.3		454.6		438.1
Current lease liabilities - operating		17.9		18.4		16.7		17.1
Income taxes payable		25.4		52.1		2.7		9.9
Accrued expenses and other current liabilities		215.4		235.1		227.2		208.3
Total current liabilities		717.6		914.4		717.8		689.4
Noncurrent liabilities
Long-term debt, net of unamortized deferred financing fees		2,297.8		2,305.6		2,299.9		2,301.6
Noncurrent lease liabilities - operating		59.3		69.2		57.2		60.2
Deferred income tax liabilities		91.5		103.2		53.7		59.8
Other noncurrent obligations		267.6		306.7		236.7		228.9
Total noncurrent liabilities		2,716.2		2,784.7		2,647.5		2,650.5
Commitments and contingencies (Note 13)
Shareholders’ equity
Ordinary shares, $0.01 nominal value, 4,000.0 shares authorized (September 30, 2022: 39.2 shares issued and 35.1 shares outstanding; December 31, 2021: 38.9 shares issued and 37.9 shares outstanding)		0.4		0.4
Ordinary shares, $0.01 nominal value, 4,000.0 shares authorized (March 31, 2023: 39.3 shares issued and 35.2 shares outstanding; December 31, 2022: 39.2 shares issued and 35.1 shares outstanding)						0.4		0.4
Preferred shares, €0.01 nominal value, 1,000.0 shares authorized (no shares issued or outstanding)		—		—		—		—
Deferred ordinary shares, €1.00 nominal value, 0.025 shares authorized (September 30, 2022: 0.025 shares issued and outstanding; December 31, 2021: 0.025 shares issued and outstanding)		—		—
Deferred ordinary shares, €1.00 nominal value, 0.025 shares authorized (March 31, 2023: 0.025 shares issued and outstanding; December 31, 2022: 0.025 shares issued and outstanding)						—		—
Additional paid-in-capital		483.7		468.1		493.3		486.7
Treasury shares, at cost (September 30, 2022: 4.1 shares; December 31, 2021: 1.0 shares)		(200.0)		(50.0)
Treasury shares, at cost (March 31, 2023: 4.1 shares; December 31, 2022: 4.1 shares)						(200.0)		(200.0)
Retained earnings		641.0		741.8		210.4		264.5
Accumulated other comprehensive loss		(227.0)		(147.2)		(127.9)		(131.3)
Total shareholders’ equity		698.1		1,013.1		376.2		420.3
Total liabilities and shareholders’ equity	$	4,131.9	$	4,712.2	$	3,741.5	$	3,760.2

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

TRINSEO PLC

Condensed Consolidated Statements of Operations

(In millions, except per share data)

(Unaudited)


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Net sales	$	1,178.1	$	1,269.3	$	3,990.3	$	3,529.0	$	996.3	$	1,386.7
Cost of sales		1,217.6		1,101.0		3,714.8		2,951.7		959.1		1,210.7
Gross profit (loss)		(39.5)		168.3		275.5		577.3
Gross profit										37.2		176.0
Selling, general and administrative expenses		80.5		76.4		262.8		230.4		84.7		96.7
Equity in earnings of unconsolidated affiliates		22.8		17.1		83.8		70.2		17.6		21.6
Other charges		1.9		1.2		39.5		3.0
Impairment and other charges										0.3		36.3
Operating income (loss)		(99.1)		107.8		57.0		414.1		(30.2)		64.6
Interest expense, net		30.4		23.0		77.7		56.6		38.3		21.9
Acquisition purchase price hedge loss		—		—		—		22.0
Other expense (income), net		0.5		(0.1)		1.6		8.4		(2.9)		3.0
Income (loss) from continuing operations before income taxes		(130.0)		84.9		(22.3)		327.1		(65.6)		39.7
Provision for (benefit from) income taxes		(12.1)		5.5		41.4		48.9		(16.7)		22.6
Net income (loss) from continuing operations		(117.9)		79.4		(63.7)		278.2		(48.9)		17.1
Net income (loss) from discontinued operations, net of income taxes		(1.9)		13.7		(1.9)		38.0
Net loss from discontinued operations, net of income taxes										—		(0.4)
Net income (loss)	$	(119.8)	$	93.1	$	(65.6)	$	316.2	$	(48.9)	$	16.7
Weighted average shares- basic		35.2		38.8		36.3		38.7		35.0		37.3
Net income (loss) per share- basic:
Continuing operations	$	(3.35)	$	2.04	$	(1.76)	$	7.19	$	(1.40)	$	0.46
Discontinued operations		(0.06)		0.35		(0.05)		0.98		—		(0.01)
Net income (loss) per share- basic	$	(3.41)	$	2.39	$	(1.81)	$	8.17	$	(1.40)	$	0.45
Weighted average shares- diluted		35.2		39.5		36.3		39.6		35.0		38.1
Net income (loss) per share- diluted:
Continuing operations	$	(3.35)	$	2.01	$	(1.76)	$	7.03	$	(1.40)	$	0.45
Discontinued operations		(0.06)		0.35		(0.05)		0.96		—		(0.01)
Net income (loss) per share- diluted	$	(3.41)	$	2.36	$	(1.81)	$	7.99	$	(1.40)	$	0.44

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

TRINSEO PLC

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In millions)

(Unaudited)


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Net income (loss)	$	(119.8)	$	93.1	$	(65.6)	$	316.2	$	(48.9)	$	16.7
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments (net of tax of $0.0, $0.0, $3.9, $0.0)		(45.0)		(1.7)		(84.1)		(2.0)
Net gain (loss) on cash flow hedges (net of tax of $0.0, $0.0, $0.6, $0.0)		(5.6)		1.2		(3.8)		5.6
Cumulative translation adjustments (net of tax of $0.0 and $0.0)										10.5		(4.3)
Net gain (loss) on cash flow hedges (net of tax (benefit) of $(2.5) and $0.0)										(7.4)		1.5
Pension and other postretirement benefit plans:
Net gain arising during period (net of tax of $0.8, $1.0, $1.6, $1.0)		2.4		9.3		10.0		9.3
Amounts reclassified from accumulated other comprehensive income		(0.9)		(1.2)		(1.9)		0.9		0.3		0.3
Total other comprehensive income (loss), net of tax		(49.1)		7.6		(79.8)		13.8		3.4		(2.5)
Comprehensive income (loss)	$	(168.9)	$	100.7	$	(145.4)	$	330.0	$	(45.5)	$	14.2

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

TRINSEO PLC

Condensed Consolidated Statements of Shareholders’ Equity

(In millions, except per share data)

(Unaudited)


	Shares			Shareholders' Equity														Shares			Shareholders' Equity
	Ordinary Shares Outstanding	Treasury Shares	Deferred Ordinary Shares	Ordinary Shares		Deferred Ordinary Shares		Additional Paid-In Capital		Treasury Shares		Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Total		Ordinary Shares Outstanding	Treasury Shares	Deferred Ordinary Shares	Ordinary Shares		Deferred Ordinary Shares		Additional Paid-In Capital		Treasury Shares		Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Total
Balance at December 31, 2022																		35.1	4.1	—	$	0.4	$	—	$	486.7	$	(200.0)	$	(131.3)	$	264.5	$	420.3
Net loss																		—	—	—		—		—		—		—		—		(48.9)		(48.9)
Other comprehensive income																		—	—	—		—		—		—		—		3.4		—		3.4
Share-based compensation activity																		0.1	—	—		—		—		6.6		—		—		—		6.6
Dividends on ordinary shares ($0.14 per share)																		—	—	—		—		—		—		—		—		(5.2)		(5.2)
Balance at March 31, 2023																		35.2	4.1	—	$	0.4	$	—	$	493.3	$	(200.0)	$	(127.9)	$	210.4	$	376.2
Balance at December 31, 2021	37.9	1.0	—	$	0.4	$	—	$	468.1	$	(50.0)	$	(147.2)	$	741.8	$	1,013.1	37.9	1.0	—	$	0.4	$	—	$	468.1	$	(50.0)	$	(147.2)	$	741.8	$	1,013.1
Net income	—	—	—		—		—		—		—		—		16.7		16.7	—	—	—		—		—		—		—		—		16.7		16.7
Other comprehensive loss	—	—	—		—		—		—		—		(2.5)		—		(2.5)	—	—	—		—		—		—		—		(2.5)		—		(2.5)
Share-based compensation activity	0.2	—	—		—		—		7.6		—		—		—		7.6	0.2	—	—		—		—		7.6		—		—		—		7.6
Purchase of treasury shares	(0.9)	0.9			—				—		(50.0)		—		—		(50.0)	(0.9)	0.9	—		—				—		(50.0)		—		—		(50.0)
Dividends on ordinary shares ($0.32 per share)	—	—	—		—		—		—		—		—		(12.1)		(12.1)	—	—	—		—		—		—		—		—		(12.1)		(12.1)
Balance at March 31, 2022	37.2	1.9	—	$	0.4	$	—	$	475.7	$	(100.0)	$	(149.7)	$	746.4	$	972.8	37.2	1.9	—	$	0.4	$	—	$	475.7	$	(100.0)	$	(149.7)	$	746.4	$	972.8
Net income	—	—	—		—		—		—		—		—		37.4		37.4
Other comprehensive loss	—	—	—		—		—		—		—		(28.2)		—		(28.2)
Share-based compensation activity	0.1	—	—		—		—		4.4		—		—		—		4.4
Purchase of treasury shares	(1.0)	1.0			—				—		(50.0)		—		—		(50.0)
Dividends on ordinary shares ($0.32 per share)	—	—	—		—		—		—		—		—		(11.8)		(11.8)
Balance at June 30, 2022	36.3	2.9	—	$	0.4	$	—	$	480.1	$	(150.0)	$	(177.9)	$	772.0	$	924.6
Net loss	—	—	—		—		—		—		—		—		(119.8)		(119.8)
Other comprehensive loss	—	—	—		—		—		—		—		(49.1)		—		(49.1)
Share-based compensation activity	—	—	—		—		—		3.6		—		—		—		3.6
Purchase of treasury shares	(1.2)	1.2	—		—		—		—		(50.0)		—		—		(50.0)
Dividends on ordinary shares ($0.32 per share)	—	—			—		—		—		—		—		(11.2)		(11.2)
Balance at September 30, 2022	35.1	4.1	—	$	0.4	$	—	$	483.7	$	(200.0)	$	(227.0)	$	641.0	$	698.1

~~Table of Contents~~

Shares

Shareholders' Equity


Ordinary Shares Outstanding

Treasury Shares

Deferred Ordinary Shares

Ordinary Shares

Deferred Ordinary Shares

Additional
Paid-In Capital

Treasury Shares

Accumulated Other Comprehensive Income (Loss)

Retained Earnings

Total
Balance at December 31, 2020

38.4

10.4

—

$
0.5

—

$
579.6

$
(542.9)

$
(186.1)

$
739.2

$
590.3
Net income

—

—

—

—

—

—

—

—

71.5

71.5
Other comprehensive income

—

—

—

—

—

—

—

6.1

—

6.1
Share-based compensation activity

0.3

(0.3)

—

—

—

(1.1)

12.9

—

—

11.8
Dividends on ordinary shares ($0.08 per share)

—

—

—

—

—

—

—

—

(3.4)

(3.4)
Balance at March 31, 2021

38.7

10.1

—

$
0.5

—

$
578.5

$
(530.0)

$
(180.0)

$
807.3

$
676.3
Net income

—

—

—

—

—

—

—

—

151.6

151.6
Other comprehensive income

—

—

—

—

—

—

—

0.1

—

0.1
Share-based compensation activity

0.1

(0.1)

—

—

—

0.2

4.7

—

—

4.9
Dividends on ordinary shares ($0.08 per share)

—

—

—

—

—

—

—

—

(3.1)

(3.1)
Balance at June 30, 2021

38.8

10.0

—

$
0.5

—

$
578.7

$
(525.3)

$
(179.9)

$
955.8

$
829.8
Net income

—

—

—

—

—

—

—

—

93.1

93.1
Other comprehensive income

—

—

—

—

—

—

—

7.6

—

7.6
Share-based compensation activity

—

—

—

—

—

3.5

0.5

—

—

4.0
Dividends on ordinary shares ($0.32 per share)

—

—

—

—

—

—

—

—

(12.5)

(12.5)
Balance at September 30, 2021

38.8

10.0

—

$
0.5

—

$
582.2

$
(524.8)

$
(172.3)

$
1,036.4

$
922.0

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

TRINSEO PLC

Condensed Consolidated Statements of Cash Flows

(In millions)

(Unaudited)


	Nine Months Ended				Three Months Ended
	September 30,				March 31,
	2022		2021		2023		2022
Cash flows from operating activities
Net income (loss)	$	(65.6)	$	316.2	$	(48.9)	$	16.7
Less: Net income (loss) from discontinued operations		(1.9)		38.0
Less: Net loss from discontinued operations						—		(0.4)
Net income (loss) from continuing operations		(63.7)		278.2		(48.9)		17.1
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities - continuing operations
Depreciation and amortization		147.1		111.0		56.0		53.0
Amortization of deferred financing fees and issuance discount		6.9		5.5		2.3		2.3
Deferred income tax		(8.0)		0.2
Deferred income tax (benefit)						(16.6)		9.0
Share-based compensation expense		15.6		11.0		8.2		8.3
Earnings of unconsolidated affiliates, net of dividends		(21.3)		(10.2)		2.4		(14.1)
Unrealized net gain (loss) on foreign exchange forward contracts		1.6		(25.2)
Acquisition purchase price hedge loss		—		22.0
Pension curtailment and settlement gain		(3.0)		(2.1)
Asset impairment charges or write-offs		3.9		3.0
Unrealized net (gain) loss on foreign exchange forward contracts						1.5		(2.6)
Unrealized net loss on commodity economic swap contracts						5.8		—
Gain on sale of businesses and other assets						—		(0.3)
Impairment charges or write-offs						0.3		0.7
Changes in assets and liabilities
Accounts receivable		5.1		(280.8)		(29.2)		(79.8)
Inventories		(43.1)		(196.7)		55.1		(66.2)
Accounts payable and other current liabilities		(81.9)		248.7		26.5		42.0
Income taxes payable		(23.7)		22.3		(7.0)		5.9
Other assets, net		13.5		(9.2)		3.8		12.7
Other liabilities, net		61.8		41.0		(14.8)		6.8
Cash provided by operating activities - continuing operations		10.8		218.7
Cash provided by (used in) operating activities - discontinued operations		(1.4)		19.5
Cash provided by operating activities		9.4		238.2
Cash provided by (used in) operating activities - continuing operations						45.4		(5.2)
Cash provided by operating activities - discontinued operations						—		0.2
Cash provided by (used in) operating activities						45.4		(5.0)
Cash flows from investing activities
Capital expenditures		(94.0)		(64.7)		(21.8)		(23.9)
Cash paid for asset or business acquisitions, net of cash acquired ($1.0 and $12.1)		(22.2)		(1,806.6)
Proceeds from the sale of businesses and other assets		5.3		0.2
Proceeds from (payments for) the settlement of hedging instruments		1.9		(14.7)
Cash paid for asset or business acquisitions, net of cash acquired ($0.0 and $1.0)						—		(22.2)
Cash used in investing activities - continuing operations		(109.0)		(1,885.8)		(21.8)		(46.1)
Cash used in investing activities - discontinued operations		(0.8)		(3.3)		—		(0.9)
Cash used in investing activities		(109.8)		(1,889.1)		(21.8)		(47.0)
Cash flows from financing activities
Deferred financing fees		—		(35.0)
Short-term borrowings, net		(12.2)		(11.6)		(2.7)		(3.6)
Purchase of treasury shares		(151.9)		—		—		(51.9)
Dividends paid		(36.3)		(9.5)		(11.8)		(12.4)
Proceeds from exercise of option awards		2.9		10.5		0.1		1.7
Withholding taxes paid on restricted share units		(3.1)		(0.8)		(1.3)		(0.8)
Acquisition-related contingent consideration payment						(1.2)		—
Repurchases and repayments of long-term debt		(12.9)		(7.1)		(3.6)		(3.6)
Net proceeds from issuance of 2028 Term Loan B		—		746.3
Net proceeds from issuance of 2029 Senior Notes		—		450.0
Proceeds from draw on Accounts Receivable Securitization Facility		—		150.0
Repayments of Accounts Receivable Securitization Facility		—		(20.0)
Cash provided by (used in) financing activities		(213.5)		1,272.8
Cash used in financing activities						(20.5)		(70.6)
Effect of exchange rates on cash		(16.3)		(3.1)		2.3		(1.7)
Net change in cash, cash equivalents, and restricted cash		(330.2)		(381.2)		5.4		(124.3)
Cash, cash equivalents, and restricted cash—beginning of period		573.0		588.7		211.7		573.0
Cash, cash equivalents, and restricted cash—end of period	$	242.8	$	207.5	$	217.1	$	448.7
Less: Restricted cash		—		—		—		—
Cash and cash equivalents—end of period	$	242.8	$	207.5	$	217.1	$	448.7

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

TRINSEO PLC

Notes to Condensed Consolidated Financial Statements

(Dollars in millions, unless otherwise stated)

(Unaudited)

NOTE 1—BASIS OF PRESENTATION

The unaudited interim condensed consolidated financial statements of Trinseo PLC and its subsidiaries (the “Company”) as of and for the periods ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect all adjustments, consisting only of normal recurring adjustments, which, in the opinion of management, are considered necessary for the fair statement of the results for the periods presented. Because they cover interim periods, the statements and related notes to the financial statements do not include all disclosures normally provided in annual financial statements, and therefore, these statements should be read in conjunction with the ~~2021~~2022 audited consolidated financial statements included within the Company’s Annual Report on Form 10-K (“Annual Report”) filed with the Securities and Exchange Commission (“SEC”) on February ~~23, 2022.~~27, 2023. The Company’s condensed consolidated financial statements presented herein reflect the latest estimates and assumptions made by management that affect the reported amounts and related disclosures as of and for the period ended ~~September 30, 2022.~~March 31, 2023. However, actual results could differ from these estimates and assumptions.

The December 31, ~~2021~~2022 condensed consolidated balance sheet data presented herein was derived from the Company’s December 31, ~~2021~~2022 audited consolidated financial statements, but does not include all disclosures required by GAAP for annual periods.

~~Certain prior year amounts have been reclassified to conform to the current year presentation.~~ Throughout this Quarterly Report, unless otherwise indicated, amounts and activity are presented on a continuing operations basis.

NOTE 2—RECENT ACCOUNTING GUIDANCE

As of ~~September 30, 2022,~~March 31, 2023, there was no recently issued accounting standards which would have a material effect on the Company’s condensed consolidated financial statements.

NOTE 3—ACQUISITIONS

Acquisition of Heathland B.V.

On January 3, 2022, the Company completed the acquisition of Heathland B.V. (“Heathland”) from Heathland Holding B.V. (“Heathland Holding”), through the purchase of all issued and outstanding shares (the “Heathland Acquisition”). ~~The Heathland Acquisition was completed pursuant to the Sale and Purchase Agreement dated December 3, 2021 (“Heathland Agreement”), by and between the Company and Heathland Holding.~~ Heathland is a leading collector and recycler of post-consumer and post-industrial plastic wastes in Europe. The total purchase price consideration is estimated to be ~~$29.3~~$29.3 million, including an initial cash purchase price of $22.9 million which was paid during the three months ended March 31, 2022, as well as $6.4 million of contingent cash consideration, representing the fair value of certain earn-out payments. The maximum amount of potential earn-out payments is $6.8 million, which ~~amounts~~ will become payable to Heathland Holding as and when the related performance milestones or thresholds are achieved over the three-year period following the date of acquisition. ~~The~~ Heathland ~~Acquisition was funded through existing cash on hand.~~

~~Table of Contents~~

Additionally, the Heathland Agreement includes a service fee of approximately $4.5 million, payable to Heathland Holdings contingent upon the continued employment of certain Heathland employees for three years following the acquisition date. The Company has not included this service fee as part of the estimated purchase price and instead will accrue for the service fee as compensation expense over the three-year period in which it is earned.

The Company accounted for the acquisition as a business combination pursuant to ASC 805. In accordance with ASC 805, fair values are assigned to tangible and identifiable intangible assets acquired and liabilities assumed at the acquisition date based on the information that was available as of the acquisition date.

The Company allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as goodwill. During the third quarter of 2022, there were no changes to the purchase price allocation for the Heathland Acquisition.

The table below summarizes the purchase price allocation for the assets acquired and liabilities assumed, based on their relative fair values, which have been assessed as of the January 3, 2022 acquisition date:

January 3,

2022
Cash and cash equivalents

$
1.0
Other current assets

1.2
Other intangible assets ⁽¹⁾

Customer relationships

5.1
Tradenames

0.9
Developed technology

0.2
Other assets

1.0
Total fair value of assets acquired

9.4

Current liabilities

(1.3)
Noncurrent liabilities

(1.6)
Total fair value of liabilities assumed

(2.9)
Net identifiable assets acquired

6.5
Purchase price consideration

29.3
Goodwill ⁽²⁾

$
22.8

~~(1)~~

~~The expected weighted average useful life of the acquired intangible assets are 7 years for customer relationships, tradenames and developed technology.~~

~~(2)~~

Goodwill largely consists of strategic and synergistic opportunities resulting from combining Heathland with the Company’s existing businesses and is allocated entirely to the Base Plastics segment. No goodwill related to this acquisition is expected to be deductible for income tax purposes.

Pro forma results of operations information have not been presented as the effect of the acquisition is not material. The operating results of the Heathland acquisition are included within the Company's condensed consolidated statements of operations since the acquisition date of January 3, 2022 and were not material for the three and nine months ended September 30, 2022. Pursuant to GAAP, costs incurred to complete the Heathland Acquisition as well as costs incurred to integrate into the Company’s operations are expensed as incurred. Transaction-related costs incurred, which are included within “Selling, general, and administrative expenses” in the condensed consolidated statements of operations, were not material for the three and nine months ended September 30, 2022.

~~Acquisition of Aristech Surfaces~~

On September 1, 2021, the Company completed its previously announced acquisition of Aristech Surfaces LLC (“Aristech Surfaces”) from SK AA Holdings LLC (“SK AA Holdings”), the sole member of Aristech Surfaces, through purchase of 100% membership interest and intellectual property (the “Aristech Surfaces Acquisition”). The purchase

~~Table of Contents~~

price consideration for the Aristech Surfaces Acquisition was $449.5 million, all of which was paid during the year ended December 31, 2021 (of which $448.0 million was paid during the nine months ended September 30, 2021). Aristech Surfaces is a leading North America manufacturer and global provider of PMMA continuous cast and solid surface sheets, serving the wellness, architectural, transportation and industrial markets, whose results are included within the ~~Engineered Materials~~Plastics Solution segment. ~~Aristech Surfaces’ products are used for a variety of applications, including the construction of hot tubs, swim spas, counter tops, signage, bath products and recreational vehicles.~~

The Company allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. Refer to the Annual Report for further information. During the nine months ended September 30, 2022, there were no changes to the purchase price allocation for the acquisition of the Aristech Surfaces business. As of September 1, 2022, the acquisition measurement period for the Aristech Surfaces business has ended and the values assigned to the assets acquired and liabilities assumed are final.

~~Acquisition of the PMMA Business~~

~~On May 3, 2021,~~In February 2023, the Company ~~completed its previously-announced acquisition of~~delivered the polymethyl methacrylates (“PMMA”) and activated methyl methacrylates (“MMA”) business (together, the “PMMA business”) from Arkema S.A., (“Arkema”) through the purchase of 100% of the shares of certain subsidiaries of Arkema (the “PMMA Acquisition”). The purchase price consideration for the PMMA Acquisition was $1,364.9 ~~million, all of which was paid during the~~first year ~~ended December 31, 2021 (of which~~ $1,358.6 million was paid during the nine months ended September 30, 2021). PMMA is a transparent and rigid plastic with a wide range of end uses, and is an attractive adjacent chemistry which complements Trinseo’s offerings across several end markets including automotive, building & construction, medical and consumer electronics. PMMA results are included within the Engineered Materials segment.

~~The Company allocated the purchase price of the acquisition~~earn-out to ~~identifiable assets acquired and liabilities assumed~~Heathland Holding based on ~~their estimated fair values as~~its first related performance milestones or threshold in the amount of the acquisition date. Refer to the Annual Report for further information. As of May 3, 2022, the acquisition measurement period for the PMMA business has ended and the values assigned to the assets acquired and liabilities assumed are final.

~~Unaudited Pro Forma Financial Information~~

The following unaudited pro forma financial information presents the consolidated results of operations of the Company with the PMMA business and Aristech Surfaces for the three and nine months ended September 30, 2021 as if these acquisitions had occurred on January l, 2021. The pro forma results were calculated by combining the results of Trinseo with the PMMA business and Aristech Surfaces but do not include adjustments related to cost savings or other synergies that are anticipated as a result of these acquisitions. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations would have been if the acquisitions had occurred as of January 1, 2021, nor are they indicative of future results of operations.

Three Months Ended

Nine Months Ended

September 30,

September 30,


2021

2021
Net sales

$
1,300.2

$
3,863.8
Net income

$
94.1

$
355.1
Income from continuing operations

$
80.4

$
317.1

$1.2 million.

NOTE 4—DIVESTITURES AND DISCONTINUED OPERATIONS

On December 1, 2021, the Company completed the divestiture of its Synthetic Rubber business to Synthos S.A. and certain of its subsidiaries (together, “Synthos”) for a purchase price of ~~$402.4~~$402.4 million, which reflected a reduction of approximately $41.6 million for the assumption of pension liabilities by Synthos and $47.0 million for net working capital (excluding inventory) retained by Trinseo. Refer to the Annual Report for further information. At closing, the Company and Synthos executed a long-term supply agreement, in which Trinseo will supply Synthos certain raw materials used in the Synthetic Rubber business subsequent to the sale. For the three months ended March 31, 2023, the

129

Table of Contents

~~materials used in the Synthetic Rubber business subsequent to the sale. For the three and nine months ended September 30, 2022, the~~ Company recorded ~~$13.8~~$13.5 million ~~and $55.6 million, respectively,~~ in net sales and ~~$14.5~~$15.4 million ~~and $46.3 million, respectively,~~ in cost of sales related to the supply agreement, which is recorded in continuing operations.

The results of the Synthetic Rubber business for the three months ended March 31, 2023 was insignificant. The following table summarizes the results of the Synthetic Rubber business for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022, ~~and 2021,~~ which are reflected as discontinued operations in the Company’s condensed consolidated statements of operations:


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2022
Net sales	$	—	$	122.3	$	0.1	$	382.2	$	0.1
Cost of sales		2.2		101.9		3.6		321.2		0.7
Gross profit (loss)		(2.2)		20.4		(3.5)		61.0
Gross loss										(0.6)
Selling, general and administrative expenses		—		4.9		(0.3)		16.7		(0.2)
Operating income (loss)		(2.2)		15.5		(3.2)		44.3
Gain on sale of businesses and other assets		—		—		1.2		—
Operating loss										(0.4)
Other expense, net		—		0.2		—		1.2		—
Income (loss) from discontinued operations before income taxes		(2.2)		15.3		(2.0)		43.1
Provision for (benefit from) income taxes		(0.3)		1.6		(0.1)		5.1
Net income (loss) from discontinued operations	$	(1.9)	$	13.7	$	(1.9)	$	38.0
Loss from discontinued operations before income taxes										(0.4)
Provision for income taxes										—
Net loss from discontinued operations									$	(0.4)

NOTE 5—NET SALES

Refer to the Annual Report for information on the Company's accounting policies and further background related to its net sales.

The following table provides disclosure of net sales to external customers by primary geographical market (based on the location where sales originated), by segment for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022.

Engineered

Latex

Base

Three Months Ended

Materials

Binders

Plastics

Polystyrene

Feedstocks

Total

September 30, 2022

United States

$
128.9

$
105.4

$
73.7

$
—

$
4.5

$
312.5

Europe

72.5

160.1

157.1

174.0

48.9

612.6

Asia-Pacific

38.9

72.9

33.3

73.7

—

218.8

Rest of World

2.4

2.5

29.3

—

—

34.2

Total

$
242.7

$
340.9

$
293.4

$
247.7

$
53.4

$
1,178.1

September 30, 2021

United States

$
102.4

$
86.3

$
82.3

$
—

$
4.0

$
275.0

Europe

89.6

153.5

247.3

162.6

50.8

703.8

Asia-Pacific

35.9

73.0

43.9

112.2

—

265.0

Rest of World

2.9

2.8

19.8

—

—

25.5

Total

$
230.8

$
315.6

$
393.3

$
274.8

$
54.8

$
1,269.3

~~Table of Contents~~


	Engineered		Latex		Base								Engineered		Latex		Plastics
Nine Months Ended	Materials		Binders		Plastics		Polystyrene		Feedstocks		Total
September 30, 2022
Three Months Ended													Materials		Binders		Solutions		Polystyrene		Feedstocks		Total
March 31, 2023
United States	$	418.0	$	290.1	$	264.3	$	—	$	13.0	$	985.4	$	110.9	$	67.6	$	68.7	$	—	$	3.6	$	250.8
Europe		300.1		480.4		602.2		604.5		207.3		2,194.5		73.5		128.1		165.3		138.5		39.4		544.8
Asia-Pacific		112.4		223.9		102.1		273.1		—		711.5		18.9		50.7		27.8		70.6		—		168.0
Rest of World		8.7		6.9		83.2		0.1		—		98.9		2.9		1.7		28.1		—		—		32.7
Total	$	839.2	$	1,001.3	$	1,051.8	$	877.7	$	220.3	$	3,990.3	$	206.2	$	248.1	$	289.9	$	209.1	$	43.0	$	996.3
September 30, 2021
March 31, 2022
United States	$	174.1	$	228.2	$	216.5	$	—	$	10.7	$	629.5	$	138.4	$	82.2	$	84.5	$	—	$	3.9	$	309.0
Europe		190.8		431.4		699.2		511.7		188.9		2,022.0		118.7		150.9		246.6		214.6		66.4		797.2
Asia-Pacific		108.1		211.1		144.5		343.3		—		807.0		35.3		71.7		37.2		103.4		—		247.6
Rest of World		4.5		6.9		59.1		—		—		70.5		2.8		1.9		28.2		—		—		32.9
Total	$	477.5	$	877.6	$	1,119.3	$	855.0	$	199.6	$	3,529.0	$	295.2	$	306.7	$	396.5	$	318.0	$	70.3	$	1,386.7

NOTE 6—INVESTMENTS IN UNCONSOLIDATED AFFILIATES

The Company is currently supplemented by one joint venture, Americas Styrenics LLC (“Americas Styrenics,” a styrene and polystyrene joint venture with Chevron Phillips Chemical Company LP), which is accounted for using the equity method. The results of Americas Styrenics are included within its own reporting segment.

Table of Contents

Americas Styrenics is a privately held company; therefore, a quoted market price for its equity interests is not available. The summarized financial information of the Company’s unconsolidated affiliate is shown below.


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Sales	$	535.3	$	433.4	$	1,654.3	$	1,351.9	$	443.3	$	524.4
Gross profit	$	70.6	$	49.3	$	212.2	$	189.2	$	52.9	$	48.1
Net income	$	48.3	$	37.2	$	164.5	$	151.8	$	37.8	$	36.1

As of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, the Company’s investment in Americas Styrenics was ~~$269.2~~$252.7 million and ~~$247.8~~$255.1 million, respectively, which was ~~$11.0~~$7.0 million and ~~$9.4~~$8.4 million greater than the Company’s 50% share of the underlying net assets of Americas Styrenics, respectively. This amount represents the difference between the book value of assets held by the joint venture and the Company’s 50% share of the total recorded value of the joint venture’s assets, inclusive of certain adjustments to conform with the Company’s accounting policies. This difference is being amortized over a weighted average remaining useful life of approximately ~~2.3~~1.8 years as of ~~September 30, 2022.~~March 31, 2023. The Company received dividends of ~~$25.0~~$20.0 million and ~~$62.5~~$7.5 million from Americas Styrenics during the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022, ~~respectively, and $20.0 million and $60.0 million during the three and nine months ended September 30, 2021,~~ respectively.

NOTE 7—INVENTORIES

Inventories consisted of the following:


	September 30,		December 31,		March 31,		December 31,
	2022		2021		2023		2022
Finished goods	$	281.7	$	279.2	$	195.3	$	218.4
Raw materials and semi-finished goods		297.5		303.9		265.9		295.6
Supplies		34.8		37.9		41.4		39.6
Total	$	614.0	$	621.0	$	502.6	$	553.6

NOTE 8—DEBT

Refer to the Annual Report for definitions of capitalized terms not included herein and further background on the Company’s debt structure discussed below. The Company was in compliance with all debt related covenants as of March 31, 2023 and December 31, 2022.

1411

Table of Contents

~~NOTE 8—DEBT~~

~~Refer to the Annual Report for definitions~~As of ~~capitalized terms not included herein and further background on the Company’s debt structure discussed below. The Company was in compliance with all debt related covenants as of September 30, 2022~~March 31, 2023 and December 31, ~~2021.~~

~~As of September 30,~~ 2022, ~~and December 31, 2021,~~ debt consisted of the following:


			September 30, 2022						December 31, 2021								March 31, 2023						December 31, 2022
	Interest Rate as of September 30, 2022	Maturity Date	Carrying Amount		Unamortized Deferred Financing Fees ⁽¹⁾		Total Debt, Less Unamortized Deferred Financing Fees		Carrying Amount		Unamortized Deferred Financing Fees ⁽¹⁾		Total Debt, Less Unamortized Deferred Financing Fees		Interest Rate as of March 31, 2023	Maturity Date	Carrying Amount		Unamortized Deferred Financing Fees ⁽¹⁾		Total Debt, Less Unamortized Deferred Financing Fees		Carrying Amount		Unamortized Deferred Financing Fees ⁽¹⁾		Total Debt, Less Unamortized Deferred Financing Fees
Senior Credit Facility
2024 Term Loan B	5.115%	September 2024	$	665.2	$	(5.9)	$	659.3	$	670.4	$	(8.0)	$	662.4	6.840%	September 2024	$	661.7	$	(4.4)	$	657.3	$	663.4	$	(5.1)	$	658.3
2028 Term Loan B	5.615%	May 2028		737.6		(15.1)		722.5		742.8		(17.0)		725.8	7.340%	May 2028		734.1		(13.8)		720.3		735.9		(14.4)		721.5
2026 Revolving Facility⁽²⁾	Various	May 2026		—		—		—		—		—		—	Various	May 2026		—		—		—		—		—		—
2029 Senior Notes	5.125%	April 2029		447.0		(13.3)		433.7		450.0		(14.7)		435.3	5.125%	April 2029		447.0		(12.5)		434.5		447.0		(12.9)		434.1
2025 Senior Notes	5.375%	September 2025		500.0		(4.0)		496.0		500.0		(5.0)		495.0	5.375%	September 2025		500.0		(3.4)		496.6		500.0		(3.7)		496.3
Accounts Receivable Securitization Facility⁽³⁾	Various	November 2024		—		—		—		—		—		—	Various	November 2024		—		—		—		—		—		—
Other indebtedness	Various	Various		3.0		—		3.0		5.6		—		5.6	Various	Various		7.8		—		7.8		7.4		—		7.4
Total debt			$	2,352.8	$	(38.3)	$	2,314.5	$	2,368.8	$	(44.7)	$	2,324.1			$	2,350.6	$	(34.1)	$	2,316.5	$	2,353.7	$	(36.1)	$	2,317.6
Less: current portion⁽⁴⁾								(16.7)						(18.5)								(16.6)						(16.0)
Total long-term debt, net of unamortized deferred financing fees							$	2,297.8					$	2,305.6							$	2,299.9					$	2,301.6

(1)

This caption does not include deferred financing fees related to the Company’s revolving facilities, which are included within “Deferred charges and other assets” on the condensed consolidated balance sheets.

(2)

As of ~~September 30, 2022,~~March 31, 2023, under the 2026 Revolving Facility, the Company had a capacity of $375.0 million and $22.0 million outstanding letters of credit. As of March 31, 2023, the Company had funds available for borrowing of ~~$369.2~~$100.5 million (net of ~~$5.8~~the applicable $12.0 million outstanding letters of ~~credit).~~credit as defined in the secured credit agreement), which reflects the borrowing limit imposed by the springing covenant. The springing covenant applies when 30% or more of the 2026 Revolving Facility’s capacity is drawn which then requires the Company to meet a first lien net leverage ratio (as defined in the secured credit agreement) not to exceed 3.50x at the end of each financial quarter. As of March 31, 2023, the first lien net leverage ratio was 4.85x and the outstanding borrowings did not exceed the 30% threshold. Additionally, the Company is required to pay a quarterly commitment fee in respect of any unused commitments under this facility equal to 0.375% per annum.

(3)

As of ~~September 30, 2022,~~March 31, 2023, this facility had a borrowing capacity of $150.0 million, and the Company had approximately $150.0 million of accounts receivable available to support this facility, based on the pool of eligible accounts receivable.

(4)

The current portion of long-term debt was primarily related to $14.5 million of the scheduled future principal payments on both the 2024 Term Loan B and 2028 Term Loan B as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021.~~2022.

NOTE 9—GOODWILL

The following table shows changes in the carrying amount of goodwill, by segment, from December 31, ~~2021~~2022 to ~~September 30, 2022:~~March 31, 2023:


	Engineered		Latex		Base						Americas				Engineered		Latex		Plastics						Americas
	Materials		Binders		Plastics		Polystyrene		Feedstocks		Styrenics		Total		Materials		Binders		Solutions		Polystyrene		Feedstocks		Styrenics		Total
Balance at December 31, 2021	$	667.3	$	15.9	$	22.4	$	4.5	$	—	$	—	$	710.1
Acquisitions (Note 3)		—		—		22.8		—		—		—		22.8
Balance at December 31, 2022															$	348.9	$	14.8	$	42.5	$	4.2	$	—	$	—	$	410.4
Foreign currency impact		(31.7)		(2.3)		(6.3)		(0.7)		—		—		(41.0)		2.6		0.3		0.8		0.1		—		—		3.8
Balance at September 30, 2022	$	635.6	$	13.6	$	38.9	$	3.8	$	—	$	—	$	691.9
Balance at March 31, 2023															$	351.5	$	15.1	$	43.3	$	4.3	$	—	$	—	$	414.2

As a result of the Company’s fourth quarter 2022 impairment testing, an impairment charge was taken for the PMMA business and Aristech Surfaces reporting units primarily due to the continuation of the challenging macroeconomic environment experienced in 2022 into the fourth quarter of 2022, including significantly lower demand

1512

Table of Contents

~~The Company tests~~for building & construction and wellness applications, which led to lower operating results including slower growth projections, and a prolonged drop in market capitalization, as well as an increase in the weighted average cost of capital. This goodwill may be at risk for future impairment ~~annually as of October 1, or more frequently when events or changes in circumstances indicate that~~due to the remaining fair value ofbeing equal to carrying value as a reporting unit is more likely than not below carrying value. As noted within Note 3 – Acquisitions and as discussed within the Annual Report, in 2021, the Company completed the PMMA Acquisition and Aristech Surfaces Acquisition, each of which represents a separate reporting unit within the Engineered Materials segment. The Company allocated the purchase price of these acquisitions to identifiable assets acquired and liabilities assumed based on their estimated fair values asresult of the ~~acquisition date, with~~recorded impairment. While the excess of the purchase price over the aggregate fair values recorded as goodwill. As of September 30, 2022, the reporting units for the PMMA business and Aristech Surfaces had goodwill balances of approximately $503.0 million and $120.0 million, respectively.

In 2022, historically high natural gas prices and depressed customer demand in Europe, COVID-19 lockdowns in China, global supply chain constraints, weakness in certain end customer applications, and an uncertain geopolitical situation in Europe, created a challenging ~~operating~~macroeconomic environment ~~for~~has continued to impact these businesses ~~negatively impacting their financial performance. In response to these conditions,~~in the first quarter of 2023, the Company performed qualitative analyses over ~~these reporting units,~~this goodwill, including consideration of current and estimated future financial results of the related businesses, general and industry-specific economic conditions, changes in ~~their respective~~reporting unit carrying values and potential changes to the assumptions used in the previous fair value calculations.

Based on these analyses, the Company has not identified any triggering events since the fourth quarter of 2022 impairment test indicating that it is more likely than not that goodwill is impaired. ~~However, these reporting units may be at risk for future impairment due to the limited amount of fair value in excess of carrying value as a result of their recent acquisition.~~ Should these conditions persist, or other events occur indicating that the estimated future cash flows of these ~~reporting units~~businesses have declined, the Company may be required to record future non-cash impairment charges related to goodwill.

As of March 31, 2023 and December 31, 2022, the reported balance of goodwill included accumulated impairment losses of $297.1 million in the Engineered Materials segment.

NOTE 10—DERIVATIVE INSTRUMENTS

The Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates, interest rate risk, and commodity price risk, in particular natural gas. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts, interest rate swap agreements, and commodity swaps agreements, forward contracts, or options. The Company does not hold or enter into financial instruments for trading or speculative purposes. All derivatives are recorded on the condensed consolidated balance sheets at fair value.

Foreign Exchange Forward Contracts

Certain subsidiaries have assets and liabilities denominated in currencies other than their respective functional currencies, which creates foreign exchange risk. The Company’s principal strategy in managing its exposure to changes in foreign currency exchange rates is to naturally hedge the foreign currency-denominated liabilities on its balance sheet against corresponding assets of the same currency, such that any changes in liabilities due to fluctuations in exchange rates are offset by changes in their corresponding foreign currency assets. In order to further reduce this exposure, the Company also uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on assets and liabilities denominated in certain foreign currencies. The Company entered into a specific such foreign exchange forward contract in December 2020 in order to economically hedge the euro-denominated purchase price of the PMMA business, which was acquired on May 3, 2021, as discussed in Note 3. These derivative contracts are not designated for hedge accounting treatment.

As of ~~September 30, 2022,~~March 31, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar equivalent absolute value of ~~$547.6~~$657.5 million. The following table displays the notional amounts of the most significant

~~Table of Contents~~

net foreign exchange hedge positions outstanding as of ~~September 30, 2022:~~March 31, 2023:


	September 30,		March 31,
Buy / (Sell)	2022		2023
Euro	$	(411.1)	$	(520.9)
Chinese Yuan	$	(46.4)	$	(48.4)
South Korean Won			$	(21.8)
Swiss Franc			$	(19.6)
Swedish Krona	$	20.7	$	14.7
South Korean Won	$	(18.3)
New Taiwan Dollar	$	15.6

Open foreign exchange forward contracts as of ~~September 30, 2022~~March 31, 2023 had maturities occurring over a period of two months.

Foreign Exchange Cash Flow Hedges

The Company also enters into forward contracts, as deemed appropriate, with the objective of managing the currency risk associated with forecasted U.S. dollar-denominated raw materials purchases by one of its subsidiaries whose functional currency is the euro. By entering into these forward contracts, which are designated as cash flow

Table of Contents

hedges, the Company buys a designated amount of U.S. dollars and sells euros at the prevailing market rate to mitigate the risk associated with the fluctuations in the euro-to-U.S. dollar foreign currency exchange rates. The qualifying hedge contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in Accumulated Other Comprehensive Income (“AOCI”) to the extent effective, and reclassified to cost of sales in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur.

The Company had no open foreign exchange cash flow hedges as of ~~September 30, 2022.~~March 31, 2023.

Commodity Cash Flow Hedges & Commodity Economic Hedges

The Company purchases certain commodities, primarily natural gas, to operate facilities and generate heat and steam for various manufacturing processes, which purchases are subject to price volatility. In order to manage the risk of price fluctuations associated with these commodity purchases, as deemed appropriate, the Company may enter into commodity swaps, forward contracts, or options. As of March 31, 2023, the Company had open commodity swap agreements, which effectively convert a portion of its natural gas costs into a fixed rate obligation. These commodity derivatives are designated as cash flow hedges, and as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective, and reclassified to cost of sales in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur.

Open commodity cash flow hedges as of ~~September 30, 2022~~March 31, 2023 had maturities occurring over a period of ~~three~~21 months and had a notional value of approximately 63964 thousand megawatt hours of natural gas purchases.

The Company may also enter into certain commodity swap agreements to economically hedge the impact of these price fluctuations, which are not designated for hedge accounting treatment. Open commodity economic hedges as of March 31, 2023 had maturities occurring over a period of 24 months and had a notional value of approximately 895 thousand megawatt hours of natural gas purchases.

Interest Rate Swaps

On September 6, 2017, the Company issued the 2024 Term Loan B, which currently bears an interest rate of LIBOR plus 2.00%, subject to a 0.00% LIBOR floor. In order to reduce the variability in interest payments associated with the Company’s variable rate debt, during 2017 the Company entered into certain interest rate swap agreements to convert a portion of these variable rate borrowings into a fixed rate obligation. These interest rate swap agreements are designated as cash flow hedges, and as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective, and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur. Under the terms of the swap agreements, with a net notional U.S. dollar equivalent of $200.0 million and an effective date of September 29, 2017, the Company was required to pay the counterparties a stream of fixed interest payments at a rate of 1.81%, and in turn, receives variable interest payments based on 1-month LIBOR from the counterparties. These interest rate swap agreements matured in September 2022, and the Company has no remaining open interest rate swap agreements.

Net Investment Hedge

The Company accounts for its cross currency swaps (“CCS”) under the spot method, meaning that changes in the fair value of the hedge included in the assessment of effectiveness (changes due to spot foreign exchange rates) are

~~Table of Contents~~

recorded within AOCI, where they remain until either the sale or substantially complete liquidation of the subsidiary subject to the hedge. Additionally, the initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument and any difference between the change in the fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI. When applicable, the Company amortizes any initial excluded component value of a CCS as a reduction of “Interest expense, net” in the condensed consolidated statements of operations using the straight-line method over the remaining term of the related CCS. Additionally, interest receipts and payments are accrued under the terms of the Company’s CCS and are recognized within “Interest expense, net” in the condensed consolidated statements of operations.

The Company entered into a CCS arrangement (the “2017 CCS”) on September 1, 2017, swapping U.S. dollar principal and interest payments of $500.0 million at an interest rate of 5.375% on its 2025 Senior Notes for euro-denominated payments of €420.0 million at a weighted average interest rate of 3.45% for approximately five years. On

Table of Contents

February 26, 2020, the Company settled its 2017 CCS and replaced it with a new CCS arrangement (the “2020 CCS”) that carried substantially the same terms as the 2017 CCS. Under the 2020 CCS, the Company notionally exchanged $500.0 million at an interest rate of 5.375% for €459.3 million at a weighted average interest rate of 3.672% for approximately 2.7 years, with a final maturity of November 3, 2022. The cash flows under the 2020 CCS are aligned with the Company’s principal and interest obligations on its 5.375% 2025 Senior Notes. Refer to the Annual Report for further information.

On April 7, 2022, the Company settled its existing 2020 CCS, which were set to mature in November 2022. Upon settlement of the 2020 CCS, the Company realized net cash proceeds of $1.9 million.

Table of Contents

Summary of Derivative Instruments

The following table presents the effect of the Company’s derivative instruments, including those not designated for hedge accounting treatment, on the condensed consolidated statements of operations for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021:~~2022:


	Location and Amount of Gain (Loss) Recognized in Statements of Operations												Location and Amount of Gain (Loss) Recognized in Statements of Operations
	Three Months Ended						Three Months Ended						Three Months Ended						Three Months Ended
	September 30, 2022						September 30, 2021						March 31, 2023						March 31, 2022
	Cost of sales		Interest expense, net		Other (expense) income, net		Cost of sales		Interest expense, net		Other (expense) income, net		Cost of sales		Interest expense, net		Other (expense) income, net		Cost of sales		Interest expense, net		Other (expense) income, net
Total amount of income and (expense) line items presented in the statements of operations in which the effects of derivative instruments are recorded	$	(1,217.6)	$	(30.4)	$	(0.5)	$	(1,101.0)	$	(23.0)	$	0.1	$	(959.1)	$	(38.3)	$	2.9	$	(1,210.7)	$	(21.9)	$	(3.0)

The effects of cash flow hedge instruments:
Foreign exchange cash flow hedges
Amount of gain reclassified from AOCI into income	$	—	$	—	$	—	$	0.3	$	—	$	—
Commodity cash flow hedges
Amount of gain reclassified from AOCI into income	$	2.0	$	—	$	—	$	—	$	—	$	—
Amount of loss reclassified from AOCI into income													$	(6.4)	$	—	$	—	$	—	$	—	$	—
Interest rate swaps
Amount of gain (loss) reclassified from AOCI into income	$	—	$	0.2	$	—	$	—	$	(0.9)	$	—
Amount of loss reclassified from AOCI into income													$	—	$	—	$	—	$	—	$	(0.8)	$	—

The effects of net investment hedge instruments:
Cross currency swaps (CCS)
Cross currency swaps
Amount of gain excluded from effectiveness testing	$	—	$	—	$	—	$	—	$	1.9	$	—	$	—	$	—	$	—	$	—	$	2.1	$	—

The effects of derivatives not designated as hedge instruments:
Foreign exchange forward contracts
Amount of gain recognized in income ⁽¹⁾	$	—	$	—	$	33.7	$	—	$	—	$	23.3
Amount of gain (loss) recognized in income													$	—	$	—	$	(7.8)	$	—	$	—	$	8.8
Commodity economic hedges
Amount of loss recognized in income													$	(12.4)	$	—	$	—	$	—	$	—	$	—

The following table presents the effect of cash flow and net investment hedge accounting on AOCI for the three months ended March 31, 2023 and 2022:


`	Gain (Loss) Recognized in AOCI on Balance Sheet
	Three Months Ended
	March 31,
	2023		2022
Designated as Cash Flow Hedges
Commodity cash flow hedges	$	(9.9)	$	—
Interest rate swaps		—		1.5
Total	$	(9.9)	$	1.5
Designated as Net Investment Hedges
Cross currency swaps (CCS)	$	—	$	6.1
Total	$	—	$	6.1

1816

Table of Contents

Location and Amount of Gain (Loss) Recognized in
Statements of Operations

Nine Months Ended

Nine Months Ended

September 30, 2022

September 30, 2021

Cost of
sales

Interest expense, net

Other (expense) income, net

Cost of
sales

Interest expense, net

Acquisition purchase price hedge gain (loss)

Other (expense) income, net
Total amount of income and (expense) line items presented in the statements of operations in which the effects of derivative instruments are recorded

$
(3,714.8)

$
(77.7)

$
(1.6)

$
(2,951.7)

$
(56.6)

$
(22.0)

$
(8.4)

The effects of cash flow hedge instruments:

Commodity cash flow hedges

Amount of gain reclassified from AOCI into income

$
2.0

$
—

$
—

$
—

$
—

$
—

$
—
Interest rate swaps

Amount of loss reclassified from AOCI into income

$
—

$
(1.2)

$
—

$
—

$
(2.6)

$
—

$
—

The effects of net investment hedge instruments:

Cross currency swaps (CCS)

Amount of gain excluded from effectiveness testing

$
—

$
2.4

$
—

$
—

$
5.5

$
—

$
—

The effects of derivatives not designated as hedge instruments:

Foreign exchange forward contracts

Amount of gain (loss) recognized in income ⁽¹⁾

$
—

$
—

$
81.6

$
—

$
—

$
(22.0)

$
43.4

~~(1)~~

The $22.0 million loss incurred from the change in fair value of the forward currency hedge arrangement on the euro-denominated purchase price of the PMMA business during the nine months ended September 30, 2021 is presented separately in the condensed consolidated statements of operations from the gains recorded on the Company’s other foreign exchange forward contracts.

~~The following table presents the effect of cash flow and net investment hedge accounting on AOCI for the three and nine months ended September 30, 2022 and 2021:~~

`

Gain (Loss) Recognized in AOCI on Balance Sheet

Three Months Ended

Nine Months Ended

September 30,

September 30,

2022

2021

2022

2021
Designated as Cash Flow Hedges

Foreign exchange cash flow hedges

$
—

$
0.4

$
—

$
3.1
Commodity cash flow hedges

(5.4)

—

(5.4)

—
Interest rate swaps

(0.2)

0.8

2.2

2.5
Total

$
(5.6)

$
1.2

$
(3.2)

$
5.6
Designated as Net Investment Hedges

Cross currency swaps (CCS)

$
—

$
13.1

$
15.8

$
32.1
Total

$
—

$
13.1

$
15.8

$
32.1

~~Table of Contents~~

Gain (Loss) Recognized in Other expense, net in Statement of Operations

Three Months Ended

Nine Months Ended

September 30,

September 30,


2022

2021

2022

2021

Settlements and changes in the fair value of forward contracts (not designated as hedges) ⁽¹⁾

$
33.7

$
23.3

$
81.6

$
43.4

Remeasurement of foreign currency-denominated assets and liabilities

$
(35.4)

$
(23.7)

$
(83.4)

$
(43.0)

Total

$
(1.7)

$
(0.4)

$
(1.8)

$
0.4

~~(1)~~

Amount does not include the loss of $22.0 million recorded from the change in fair value of the forward currency hedge arrangement on the euro-denominated purchase price of the PMMA business during the nine months ended September 30, 2021.


	Gain (Loss) Recognized in Other expense (income), net in Statement of Operations
	Three Months Ended
	March 31,
	2023		2022
Settlements and changes in the fair value of forward contracts (not designated as hedges)	$	(7.8)	$	8.8
Remeasurement of foreign currency-denominated assets and liabilities	$	10.5	$	(10.2)
Total	$	2.7	$	(1.4)

The Company expects to reclassify in the next twelve months an approximate ~~$5.4~~$23.0 million net loss from AOCI into earnings related to the Company’s outstanding commodity cash flow hedges as of ~~September 30, 2022.~~March 31, 2023, based on current commodity price indices.

The following tables summarize the gross and net unrealized gains and losses, as well as the balance sheet classification, of outstanding derivatives recorded in the condensed consolidated balance sheets:


	September 30, 2022						March 31, 2023
	Foreign						Foreign
	Exchange		Commodity				Exchange		Commodity		Commodity
Balance Sheet	Forward		Cash Flow				Forward		Economic		Cash Flow
Classification	Contracts		Hedges		Total		Contracts		Hedges		Hedges		Total
Asset Derivatives:
Accounts receivable, net of allowance	$	11.5	$	—	$	11.5	$	0.1	$	—	$	0.1	$	0.2
Gross derivative asset position		11.5		—		11.5		0.1		—		0.1		0.2
Less: Counterparty netting		(0.7)		—		(0.7)		(0.1)		—		(0.1)		(0.2)
Net derivative asset position	$	10.8	$	—	$	10.8	$	—	$	—	$	—	$	—
Liability Derivatives:
Accounts payable	$	(0.7)	$	(1.8)	$	(2.5)	$	(12.5)	$	(13.5)	$	(23.1)	$	(49.1)
Other noncurrent obligations								—		(1.9)		(2.5)		(4.4)
Gross derivative liability position		(0.7)		(1.8)		(2.5)		(12.5)		(15.4)		(25.6)		(53.5)
Less: Counterparty netting		0.7		—		0.7		0.1		—		0.1		0.2
Net derivative liability position	$	—	$	(1.8)	$	(1.8)	$	(12.4)	$	(15.4)	$	(25.5)	$	(53.3)
Total net derivative position	$	10.8	$	(1.8)	$	9.0	$	(12.4)	$	(15.4)	$	(25.5)	$	(53.3)


	December 31, 2022
	Foreign
	Exchange		Commodity		Commodity
Balance Sheet	Forward		Economic		Cash Flow
Classification	Contracts		Hedges		Hedges		Total
Asset Derivatives:
Accounts receivable, net of allowance	$	0.2	$	—	$	—	$	0.2
Gross derivative asset position		0.2		—		—		0.2
Less: Counterparty netting		(0.1)		—		—		(0.1)
Net derivative asset position	$	0.1	$	—	$	—	$	0.1
Liability Derivatives:
Accounts payable	$	(11.1)	$	(5.3)	$	(11.3)	$	(27.7)
Other noncurrent obligations		—		(1.3)		(0.9)		(2.2)
Gross derivative liability position		(11.1)		(6.6)		(12.2)		(29.9)
Less: Counterparty netting		0.1		—		—		0.1
Net derivative liability position	$	(11.0)	$	(6.6)	$	(12.2)	$	(29.8)
Total net derivative position	$	(10.9)	$	(6.6)	$	(12.2)	$	(29.7)

2017

Table of Contents

December 31, 2021


Foreign

Exchange

Interest

Cross

Balance Sheet

Forward

Rate

Currency

Classification

Contracts

Swaps

Swaps

Total

Asset Derivatives:

Accounts receivable, net of allowance

$
2.3

$
—

$
—

$
2.3

Gross derivative asset position

2.3

—

—

2.3

Less: Counterparty netting

(0.1)

—

—

(0.1)

Net derivative asset position

$
2.2

$
—

$
—

$
2.2

Liability Derivatives:

Accounts payable

$
(1.3)

$
(2.2)

$
(17.4)

$
(20.9)

Gross derivative liability position

(1.3)

(2.2)

(17.4)

(20.9)

Less: Counterparty netting

0.1

—

—

0.1

Net derivative liability position

$
(1.2)

$
(2.2)

$
(17.4)

$
(20.8)

Total net derivative position

$
1.0

$
(2.2)

$
(17.4)

$
(18.6)

Forward contracts, interest rate swaps, commodity forward contracts, swaps, or options, and cross currency swaps are entered into with a limited number of counterparties, each of which allows for net settlement of all contracts through a single payment in a single currency in the event of a default on or termination of any one contract. As such, in accordance with the Company’s accounting policy, these derivative instruments are recorded on a net basis by counterparty within the condensed consolidated balance sheets.

Refer to Notes 11 and 18 of the condensed consolidated financial statements for further information regarding the fair value of the Company’s derivative instruments and the related changes in AOCI.

NOTE 11—FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date.

Level 1—Valuation is based upon quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2—Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3—Valuation is based upon other unobservable inputs that are significant to the fair value measurement.

The following table summarizes the basis used to measure certain assets and liabilities at fair value on a recurring basis in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:


	March 31, 2023
	Quoted Prices in Active Markets for Identical Items		Significant Other Observable Inputs		Significant Unobservable Inputs
Assets (Liabilities) at Fair Value	(Level 1)		(Level 2)		(Level 3)		Total
Foreign exchange forward contracts—(Liabilities)	$	—	$	(12.4)	$	—	$	(12.4)
Commodity economic hedges—(Liabilities)		—		(15.4)		—		(15.4)
Commodity cash flow hedges—(Liabilities)		—		(25.5)		—		(25.5)
Total fair value	$	—	$	(53.3)	$	—	$	(53.3)

2118

Table of Contents

The following table summarizes the basis used to measure certain assets and liabilities at fair value on a recurring basis in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021:

September 30, 2022

Quoted Prices in Active Markets for Identical Items

Significant Other Observable Inputs

Significant Unobservable Inputs

Assets (Liabilities) at Fair Value

(Level 1)

(Level 2)

(Level 3)

Total

Foreign exchange forward contracts—Assets

$
—

$
10.8

$
—

$
10.8

Commodity cash flow hedges—(Liabilities)

—

(1.8)

—

(1.8)

Total fair value

$
—

$
9.0

$
—

$
9.0


	December 31, 2021								December 31, 2022
	Quoted Prices in Active Markets for Identical Items		Significant Other Observable Inputs		Significant Unobservable Inputs				Quoted Prices in Active Markets for Identical Items		Significant Other Observable Inputs		Significant Unobservable Inputs
Assets (Liabilities) at Fair Value	(Level 1)		(Level 2)		(Level 3)		Total		(Level 1)		(Level 2)		(Level 3)		Total
Foreign exchange forward contracts—Assets	$	—	$	2.2	$	—	$	2.2	$	—	$	0.1	$	—	$	0.1
Foreign exchange forward contracts—(Liabilities)		—		(1.2)		—		(1.2)		—		(11.0)		—		(11.0)
Interest rate swaps—(Liabilities)		—		(2.2)		—		(2.2)
Cross currency swaps—(Liabilities)		—		(17.4)		—		(17.4)
Commodity economic hedges—(Liabilities)										—		(6.6)		—		(6.6)
Commodity cash flow hedges—(Liabilities)										—		(12.2)		—		(12.2)
Total fair value	$	—	$	(18.6)	$	—	$	(18.6)	$	—	$	(29.7)	$	—	$	(29.7)

The Company uses an income approach to value its derivative instruments, utilizing discounted cash flow techniques, considering the terms of the contract and observable market information available as of the reporting date, such as interest rate yield curves and currency spot and forward rates. Significant inputs to the valuation for these derivative instruments are obtained from broker quotations or from listed or over-the-counter market data, and are classified as Level 2 in the fair value hierarchy.

Nonrecurring Fair Value Measurements

The Company measured certain financial assets at fair value on a nonrecurring basis during the year ended December 31, ~~2021,~~2022, which were still held as of ~~September 30, 2022.~~March 31, 2023. These financial assets represent the Company’s styrene monomer assets in Boehlen, Germany, which it ~~continues~~continued to ~~operate.~~operate until the fourth quarter of 2022 when the Company decided to close this plant in connection with the asset restructuring plan. Refer to Note 17 for further information. These assets were measured at fair value using underlying fixed asset records in conjunction with the use of industry experience and available market data, which are classified as Level 3 significant unobservable inputs in the fair value hierarchy. During the three ~~and nine~~ months ended ~~September 30, 2022,~~March 31, 2023, the Company recorded additional impairment charges of ~~$1.9~~$0.3 million ~~and $3.9 million, respectively,~~ related to capital expenditures at the Boehlen styrene monomer facility that it determined to be impaired, which are also included within ~~“Other~~“Impairment and other charges” on the condensed consolidated statements of operations. Refer to the Company’s Annual Report for further information. As of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, the value of the Boehlen styrene monomer assets are recorded at ~~$2.9~~$3.2 million ~~and $3.4 million, respectively,~~ within the Company’s condensed consolidated balance sheets herein.

There were no other financial assets or liabilities measured at fair value on a nonrecurring basis as of December 31, ~~2021.~~2022.

2219

Table of Contents

Fair Value of Debt Instruments

The following table presents the estimated fair value of the Company’s outstanding debt not carried at fair value as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021:~~2022:


	As of		As of		As of		As of
	September 30, 2022		December 31, 2021		March 31, 2023		December 31, 2022
2029 Senior Notes	$	268.2	$	460.2	$	269.1	$	292.3
2028 Term Loan B		685.5		737.4		662.1		687.1
2025 Senior Notes		393.7		509.4		406.8		416.9
2024 Term Loan B		639.8		667.5		653.8		645.6
Total fair value	$	1,987.2	$	2,374.5	$	1,991.8	$	2,041.9

The fair value of the Company’s debt facilities above (each Level 2 securities) is determined using over-the-counter market quotes and benchmark yields received from independent vendors. Fair value amount presented reflect the Company’s carrying value of debt, net of original issuance discount.

There were no other significant financial instruments outstanding as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021.~~2022.

NOTE 12—PROVISION FOR INCOME TAXES


	Three Months Ended						Nine Months Ended						Three Months Ended
	September 30,						September 30,						March 31,
	2022			2021			2022			2021			2023			2022
Effective income tax rate		9.3	%		6.5	%		(185.2)	%		14.9	%		25.4	%		56.9	%

~~Provision for (benefit from)~~Benefit from income taxes for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 totaled ~~$(12.1)~~$16.7 million, ~~and $41.4 million, respectively,~~ resulting in an effective tax rate of ~~9.3% and (185.2)%, respectively.~~25.4%. Provision for income taxes for the three ~~and nine~~ months ended ~~September 30, 2021~~March 31, 2022 totaled ~~$5.5~~$22.6 million, ~~and $48.9 million, respectively,~~ resulting in an effective tax rate of ~~6.5% and 14.9%, respectively.~~56.9%.

The most significant driver of the ~~changes~~decrease in the effective income tax rate for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 compared to the prior year was the change in the Company’s forecasted jurisdictional mix of earnings, where income expected to be generated in higher rate jurisdictions exceeds income expected to be generated in lower rate ~~jurisdictions.~~jurisdictions, partially offset by losses not anticipated to provide a tax benefit.

~~Also impacting the~~The effective income tax rate for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 was the revaluation of the Company’s net deferred tax assets in Switzerland, which were originally established as part of the Swiss cantonal tax reform measures enacted in 2019. This revaluation resulted in a one-time deferred tax expense of $15.3 million recorded in the second quarter of 2022. This expense was partially offset by the release of a valuation allowance of $8.5 million during the second quarter of 2022, as a result of improvements in actual and projected future results in one of the Company’s subsidiaries in Luxembourg. Additionally, the effective income tax rate for this period wasprimarily impacted by a $35.6 million charge ~~recorded in the first quarter of 2022~~ related to the European Commission request for information, as described within Note 13 in the condensed consolidated financial statements, for which the Company estimates no tax ~~benefit based on currently available information.~~benefit.

The effective income tax rate for the three and nine months ended September 30, 2021 was significantly impacted by the release of a valuation allowance of $16.3 million, as a result of improvements in actual business operations and projected future results of one of the Company’s subsidiaries in China.

NOTE 13—COMMITMENTS AND CONTINGENCIES

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law, existing technologies and other information. Pursuant to the terms of the agreement associated with the Company’s formation, the pre-closing environmental

~~Table of Contents~~

liabilities were retained by Dow, and Dow agreed, subject to temporal, monetary, and other limitations to indemnify the Company from and against environmental liabilities incurred or relating to the predecessor periods. Other than certain immaterial environmental liabilities assumed as part of the PMMA Acquisition and the Aristech Surfaces Acquisition, no material environmental claims have been asserted ~~or threatened~~ against the ~~Company. The~~ Company, isand the Company does not ~~a potentially responsible party for~~have any material ~~amounts at~~accrued obligations for any Superfund Sites. As of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, the Company had ~~$4.1~~$3.5 million ~~and $4.4 million, respectively,~~ of accrued obligations for environmental remediation or restoration costs, which were recorded at fair value within the opening balance sheets of the PMMA business and Aristech Surfaces during 2021.

Table of Contents

On March 24, 2023, due to equipment failure at the Bristol, Pennsylvania facility, operated by our wholly-owned subsidiary, Altuglas LLC, an accidental release of a latex emulsion product occurred, which ultimately flowed into a local waterway (the “Bristol Spill”). We reported the event and cooperated closely with local, state, and federal authorities on the response activities. Water sampling conducted by the authorities did not detect site-related material in the waterway. See “Litigation Matters”below for information on environmental proceedings related to this incident. In the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material.

Inherent uncertainties exist in the Company’s potential environmental liabilities primarily due to unknown conditions, whether future claims may fall outside the scope of the indemnity, changing governmental regulations and legal standards regarding liability, and evolving technologies for handling site remediation and restoration. In connection with the Company’s existing indemnification, the possibility is considered remote that environmental remediation costs will have a material adverse impact on the condensed consolidated financial statements over the next 12 months.

Purchase Commitments

In the normal course of business, the Company has certain raw material purchase contracts where it is required to purchase certain minimum volumes at current market prices. These commitments range from one to ~~five~~four years. In certain raw material purchase contracts, the Company has the right to purchase less than the required minimums and pay a liquidated damages fee, or, in case of a permanent plant shutdown, to terminate the contracts. In such cases, these obligations would be less than the annual commitment as disclosed in the Notes to Consolidated Financial Statements included in the Annual Report.

~~During~~Asset Retirement Obligations

The Company has built certain manufacturing facilities on leased land and is required to remove these facilities at the ~~three~~end of the corresponding contract term. Legal obligations for these demolition and ~~nine months ended September 30,~~decommissioning activities exist in connection with the retirement of these assets triggered upon closure of the facilities. In instances when the Company plans to continue operations at these facilities indefinitely, and therefore, a reasonable estimate of fair value cannot be determined, an asset retirement obligation is not recognized.

In connection with the Asset Restructuring Plan as described within Note 17, the Company concluded the Boehlen, Germany site no longer had an indeterminate life. Accordingly, during the fourth quarter of 2022, the Company recorded the fair value of an asset retirement obligation and a ~~one-time charge~~corresponding asset retirement cost, which was capitalized as part of ~~approximately $19.0 million~~the carrying amount of the related ~~to raw material purchase contract obligations. This estimated liability, which~~long-lived assets and depreciated over the asset’s shortened useful life. The asset retirement cost was fully depreciated during the fourth quarter of 2022.


	Balance at
Change in asset retirement obligation	March 31, 2023
Balance at beginning of period	$	35.8
Obligations incurred		0.9
Settlements		(2.2)
Accretion expense		0.5
Currency translation adjustment		0.6
Balance at end of period	$	35.6

Accretion expense is ~~subject to change, was recorded~~included within ~~“Cost of sales”~~“Selling, general and administrative expenses” in the condensed consolidated ~~statements~~statement of operations. The current portion of the asset retirement obligation is recorded within “Accrued expenses and other current liabilities” and the long-term portion is recorded within “Other noncurrent obligations” in the condensed consolidated balance sheets. As of March 31, 2023 and December 31, 2022, the current portion was $24.6 million and $25.3 million, respectively, and the long-term portion was $11.0 million and $10.5 million, respectively.

Litigation Matters

From time to time, the Company may be subject to various legal claims and proceedings incidental to the normal conduct of business, relating to such matters as employees, product liability, antitrust/competition, past waste disposal practices and release of chemicals into the environment. While it is impossible at this time to determine with certainty the ultimate outcome of these routine claims, the Company does not believe that the ultimate resolution of these claims

Table of Contents

will have a material adverse effect on the Company’s results of operations, financial condition or cash flow. Legal costs, including those legal costs expected to be incurred in connection with a loss contingency, are expensed as incurred.

Legal Proceedings related to the Bristol Spill

(a)

Jonnie Helfrich v. Trinseo PLC (No. 2:23-cv-01525) (United States District Court for the Eastern District of Pennsylvania)

On April 20, 2023, a complaint was filed which purports to be on behalf of a class of purchasers of the Company’s securities between May 3, 2021 and March 27, 2023. It names as defendants the Company and our chief executive officer and chief financial officer, and seeks unspecified damages and other relief for alleged violations of Sections 10(b) and 20(a) of, and Rule 10b-5 under, of the Securities Exchange Act of 1934. Given the early stage of this matter, we are not able to estimate whether a material loss to our business is probable or remote, or estimate a potential range of loss, if any. The Company intends to vigorously defend this action.

(b)

Timothy McGraw, Emily Cohen & Danielle Byrd v. Altuglas LLC and Trinseo LLC (Court of Common Pleas of Philadelphia County)

On March 29, 2023, a putative class action complaint was filed which seeks to certify a class that could potentially include all persons and entities that reside in the area served by the Baxter Drinking Water Treatment Plant. The plaintiffs allege claims of breach of duty of care based on negligence as a result of the Bristol Spill, as well as other causes of action, and seek compensatory damages, restitution, or refund of damages, including actual, statutory, and punitive damages, as well as injunctive relief. Given the early stage of this matter, we are not able to estimate whether a material loss to our business is probable or remote, or estimate a potential range of loss, if any. The Company intends to vigorously defend this action.

(c)

Environmental Proceedings

On March 25, 2023, the Company received a Notice of Federal Interest from the United States Coast Guard (“USCG”), identifying the Company as a “potentially responsible party” (“PRP”) related to the Bristol Spill. The Company also received a Notice of Federal Assumption and an Administrative Order, dated April 20, 2023 from the USCG, identifying the Company as a PRP related to the Bristol Spill. The USCG notices and order do not designate specific fines or penalties against the Company. It is not possible at this time for the Company to estimate its ultimate liability pursuant to the USCG notices or order, or other potential administrative actions related to the Bristol Spill, whether a material loss to our business is probable or remote, or estimate a potential range of loss, if any.

Synthos Matter

On November 21, 2022, the Company received formal notice from the German Arbitration Institute that Synthos had initiated an arbitration dispute on October 14, 2022 against Trinseo and its following subsidiaries: Trinseo Deutschland GmbH, Trinseo Belgium BV, Trinseo Europe GmbH, and Trinseo Export GmbH, related to Synthos’ purchase of Trinseo’s Rubber Business in 2021.

As discussed in Note 4, Synthos and Trinseo are parties to an asset purchase agreement (“APA”) dated May 21, 2021, whereby Trinseo transferred its Rubber Business to Synthos, pending regulatory approval and other administrative pre-closing conditions, for an enterprise value of approximately $491.0 million. This transaction formally closed on December 1, 2021. Synthos claims that Trinseo did not properly disclose certain information including the natural gas pricing mechanism for the steam which is supplied by a third party to the Rubber Business. Synthos is seeking non-monetary restitution and monetary damages related to the spike of utility prices in Germany that commenced in the fall of 2021.

The Company believes it has valid and prevailing defenses to Synthos’ claims and intends to vigorously defend itself against all allegations.

European Commission Request for Information

On June 6, 2018, Trinseo Europe GmbH, a subsidiary of the Company, received a request for information in the form of a letter from the European Commission Directorate General for Competition (the “European Commission”) related to styrene monomer commercial activity in the European Economic Area. The Company

Table of Contents

subsequently commenced an internal investigation into these commercial activities and discovered instances of inappropriate activity. On October 28, 2019, a supplemental request for information was received from the European Commission. This request was limited to historical employment, entity, and organizational structures, along with certain financial, styrene purchasing, and styrene market information, as well as certain spot styrene purchase contracts. The Company has provided all information requested and continues to fully cooperate with the European Commission.

As a result of further developments in this matter, during the first quarter of 2022, the Company recorded a charge of $35.6 million which is included within ~~“Other~~“Impairment and other charges” on the condensed consolidated statements of operations. ~~As of September 30,~~In November 2022, the ~~estimated liability recorded on~~Company reached a final settlement with the ~~balance sheet related to~~European Commission in respect of this matter ~~was $31.2~~of $33.8 million, adjusted for foreign exchange rate ~~impacts.~~ impacts, which was subsequently paid in full in December 2022.

NOTE 14—PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

The components of net periodic benefit costs for all significant plans were as follows:


	Three Months Ended				Three Months Ended
	March 31,				March 31,
	Non-U.S. Defined Benefit Pension Plans				U.S. Defined Benefit Pension
	2023		2022		2023		2022
Net periodic benefit cost
Service cost	$	2.0	$	3.2	$	0.1	$	0.2
Interest cost		1.7		0.7		0.2		0.2
Expected return on plan assets		(0.2)		(0.1)		(0.1)		(0.2)
Amortization of prior service credit		(0.1)		(0.1)		—		—
Amortization of net loss		(0.8)		0.7		—		—
Net periodic benefit cost	$	2.6	$	4.4	$	0.2	$	0.2

The Company ~~is unable to predict~~had less than $0.2 million of net periodic benefit costs for its other postretirement plans for the ultimate outcome of this matter, which remains ongoing. Based on its findings, the European Commission may decide to adopt a final decision imposing additional fines and/or request certain behavioral or structural commitments from the Company. However, any additional potential losses incurred could be materialthree months ended March 31, 2023 and 2022.

Service cost related to the Company’s ~~results~~defined benefit pension plans and other postretirement plans is included within “Cost of ~~operations,~~sales” and “Selling, general and administrative expenses,” whereas all other components of net periodic benefit cost are included within “Other expense (income), net” in the condensed consolidated statements of operations. As of March 31, 2023 and December 31, 2022, the Company’s benefit obligations included primarily in “Other noncurrent obligations” in the condensed consolidated balance ~~sheet,~~sheets were $183.4 million and $177.8 million, respectively.

The Company made cash ~~flows.~~contributions and benefit payments to unfunded plans of approximately $1.7 million during the three months ended March 31, 2023. The Company expects to make additional cash contributions, including benefit payments to unfunded plans, of approximately $11.4 million to its defined benefit plans for the remainder of 2023.

NOTE 15—SHARE-BASED COMPENSATION

Refer to the Annual Report for definitions of capitalized terms not included herein and further background on the Company’s share-based compensation programs included in the tables below.

The following table summarizes the Company’s share-based compensation expense for the three months ended March 31, 2023 and 2022, as well as unrecognized compensation cost as of March 31, 2023:

2423

Table of Contents

~~NOTE 14—PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS~~

~~The components of net periodic benefit costs for all significant plans were as follows:~~

Three Months Ended

Three Months Ended

September 30,

September 30,

Non-U.S. Defined Benefit Pension Plans

U.S. Defined Benefit Pension ⁽¹⁾


2022

2021

2022

2021

Net periodic benefit cost


Service cost

$
3.0

$
4.0

$
0.2

$
0.2

Interest cost

0.6

0.2

0.2

0.2

Expected return on plan assets

(0.1)

(0.1)

(0.2)

(0.2)

Amortization of prior service credit

(0.1)

(0.5)

—

—

Amortization of net loss

0.6

1.6

—

—

Settlement and curtailment gain

(1.2)

(2.3)

(0.2)

—

Net periodic benefit cost

$
2.8

$
2.9

$
—

$
0.2

Nine Months Ended

Nine Months Ended

September 30,

September 30,

Non-U.S. Defined Benefit Pension Plans

U.S. Defined Benefit Pension ⁽¹⁾


2022

2021

2022

2021

Net periodic benefit cost


Service cost

$
9.3

$
12.1

$
0.7

$
0.3

Interest cost

2.0

1.1

0.5

0.3

Expected return on plan assets

(0.2)

(0.2)

(0.7)

(0.4)

Amortization of prior service credit

(0.3)

(0.9)

—

—

Amortization of net loss

1.9

4.7

—

—

Settlement and curtailment gain

(3.1)

(2.3)

(0.2)

—

Net periodic benefit cost

$
9.6

$
14.5

$
0.3

$
0.2

~~(1)~~

~~The Company’s U.S. defined benefit pension plans were acquired in 2021, primarily in conjunction with the PMMA Acquisition.~~

~~The Company had less than $0.1 million of net periodic benefit costs for its other postretirement plans for the three and nine months ended September 30, 2022 and 2021.~~

Service cost related to the Company’s defined benefit pension plans and other postretirement plans is included within “Cost of sales” and “Selling, general and administrative expenses,” whereas all other components of net periodic benefit cost are included within “Other expense, net” in the condensed consolidated statements of operations. As of September 30, 2022 and December 31, 2021, the Company’s benefit obligations included primarily in “Other noncurrent obligations” in the condensed consolidated balance sheets were $237.8 million and $274.7 million, respectively.

The Company made cash contributions and benefit payments to unfunded plans of approximately $1.4 million and $6.1 million during the three and nine months ended September 30, 2022, respectively. The Company expects to make additional cash contributions, including benefit payments to unfunded plans, of approximately $2.7 million to its defined benefit plans for the remainder of 2022.

~~Table of Contents~~

~~NOTE 15—SHARE-BASED COMPENSATION~~

~~Refer to the Annual Report for definitions of capitalized terms not included herein and further background on the Company’s share-based compensation programs included in the tables below.~~

The following table summarizes the Company’s share-based compensation expense for the three and nine months ended September 30, 2022 and 2021, as well as unrecognized compensation cost as of September 30, 2022:


									As of							As of
	Three Months Ended				Nine Months Ended				September 30, 2022			Three Months Ended				March 31, 2023
	September 30,				September 30,				Unrecognized		Weighted	March 31,				Unrecognized		Weighted
	2022		2021		2022		2021		Compensation Cost		Average Years	2023		2022		Compensation Cost		Average Years
RSUs	$	2.1	$	2.1	$	9.1	$	5.7	$	11.3	1.7	$	4.8	$	4.6	$	13.5	2.0
Options		0.6		1.2		4.4		3.5		2.7	1.4		2.6		3.0		3.9	1.6
PSUs		0.7		0.7		2.1		1.8		4.4	2.0		0.8		0.7		7.4	2.4
Total share-based compensation expense	$	3.4	$	4.0	$	15.6	$	11.0				$	8.2	$	8.3

The following table summarizes awards granted and the respective weighted average grant date fair value for the ~~nine~~three months ended ~~September 30, 2022:~~March 31, 2023:


	Nine Months Ended				Three Months Ended
	September 30, 2022				March 31, 2023
	Awards Granted		Weighted Average Grant Date Fair Value per Award		Awards Granted		Weighted Average Grant Date Fair Value per Award
RSUs		197,986	$	52.10		394,292	$	24.10
Options		192,175		22.52		438,727		10.86
PSUs		63,317		57.47		219,238		20.23

Option Awards

The following are the weighted average assumptions used within the Black-Scholes pricing model for the Company’s option awards granted during the ~~nine~~three months ended ~~September 30, 2022:~~March 31, 2023:


	~~Nine~~Three Months Ended
	~~September 30, 2022~~March 31, 2023
Expected term (in years)	5.50
Expected volatility	~~48.72~~54.01	%
Risk-free interest rate	~~1.97~~4.06	%
Dividend yield	2.00	%

The expected volatility assumption is determined based on the historical volatility of the Company’s publicly traded ordinary shares. The expected term of option awards represents the period of time that option awards granted are expected to be outstanding. For the option awards granted during the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, the simplified method was used to calculate the expected term, given the Company’s limited historical exercise data. The risk-free interest rate for the periods within the expected term of option awards is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is estimated based on historical and expected dividend activity.

~~Table of Contents~~

Performance Share Units (PSUs)

The following are the weighted average assumptions used within the Monte Carlo valuation model for PSUs granted during the ~~nine~~three months ended ~~September 30, 2022:~~March 31, 2023:


		Nine Months Ended			Three Months Ended
		September 30, 2022			March 31, 2023
Expected term (in years)		3.00			3.00
Expected volatility		57.30	%		62.60	%
Risk-free interest rate		1.73	%		4.41	%
Share price	$	58.64		$	24.08

Determining the fair value of PSUs requires considerable judgment, including estimating the expected volatility of the price of the Company’s ordinary shares, the correlation between the Company’s share price and that of its peer companies, and the expected rate of interest. The expected volatility for each grant is determined based on the historical volatility of the Company’s ordinary shares. The expected term of PSUs represents the length of the performance period.

Table of Contents

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a duration equivalent to the performance period. The share price is the closing price of the Company’s ordinary shares on the grant date.

NOTE 16—SEGMENTS

The Company operates under six segments: Engineered Materials, Latex Binders, ~~Base~~ Plastics Solutions, Polystyrene, Feedstocks, and Americas Styrenics. On January 1, 2023, the Base Plastics segment was renamed to Plastics Solutions to better reflect Trinseo’s strategic focus on providing solutions in areas such as sustainability and material substitution. The Engineered Materials segment includes the Company’s compounds and blends products sold into higher growth and value applications, such as consumer electronics and medical, as well as soft thermoplastic elastomers (“TPEs”) products which are sold into markets such as footwear and automotive. Additionally, following the PMMA Acquisition ~~on May 3, 2021~~ and the Aristech Surfaces Acquisition ~~on September 1,~~in 2021, the Engineered Materials segment also includes PMMA and MMA products, which are sold into a variety of applications including automotive, building & construction, medical, consumer electronics, and wellness, among others. The Latex Binders segment produces styrene-butadiene latex (“SB latex”) and other latex polymers and binders, primarily for coated paper and packaging board, carpet and artificial turf backings, as well as a number of performance latex binders applications, such as adhesive, building and construction and the technical textile paper market. The ~~Base~~ Plastics Solutions segment contains the results of the acrylonitrile-butadiene-styrene (“ABS”), styrene-acrylonitrile (“SAN”), and polycarbonate (“PC”) businesses, as well as compounds and blends for automotive and other applications. The ~~Base~~ Plastics Solutions segment also includes the results of Heathland, which was acquired in the first quarter of 2022. The Polystyrene segment includes a variety of general purpose polystyrenes (“GPPS”) and polystyrene that has been modified with polybutadiene rubber to increase its impact resistant properties (“HIPS”). The Feedstocks segment includes the Company’s production and procurement of styrene monomer outside of North America, which is used as a key raw material in many of the Company’s products, including polystyrene, SB latex, and ABS resins. Lastly, the Americas Styrenics segment consists solely of the operations of the Company’s 50%-owned joint venture, Americas Styrenics, a producer of both styrene monomer and polystyrene in North America.

The following table provides disclosure of the Company’s segment Adjusted EBITDA, which is used to measure segment operating performance and is defined below, for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022. Asset and intersegment sales information by reporting segment is not regularly reviewed or included with the Company’s reporting to the chief operating decision maker. Therefore, this information has not been disclosed below.

~~Table of Contents~~

Refer to Note 5 for the Company’s net sales to external customers by segment for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022.

Engineered

Latex

Base

Americas

Three Months Ended ⁽¹⁾

Materials

Binders

Plastics

Polystyrene

Feedstocks

Styrenics

September 30, 2022

$
7.5

$
31.0

$
(14.9)

$
18.7

$
(78.0)

$
22.8

September 30, 2021

$
32.7

$
37.1

$
87.9

$
51.2

$
(27.6)

$
17.1

Engineered

Latex

Base

Americas

Nine Months Ended ⁽¹⁾

Materials

Binders

Plastics

Polystyrene

Feedstocks

Styrenics

September 30, 2022

$
76.2

$
90.6

$
99.8

$
87.0

$
(59.8)

$
83.8

September 30, 2021

$
68.5

$
86.2

$
235.0

$
149.6

$
58.5

$
70.2


	Engineered		Latex		Plastics						Americas
Three Months Ended ⁽¹⁾	Materials		Binders		Solutions		Polystyrene		Feedstocks		Styrenics
March 31, 2023	$	(11.7)	$	26.0	$	25.6	$	15.7	$	(10.8)	$	17.6
March 31, 2022	$	34.7	$	30.2	$	68.6	$	45.3	$	4.1	$	21.6

(1)

The Company’s primary measure of segment operating performance is Adjusted EBITDA, which is defined as income from continuing operations before interest expense, net; provision for income taxes; depreciation and amortization expense; loss on extinguishment of long-term debt; asset impairment charges; gains or losses on the dispositions of businesses and assets; restructuring charges; acquisition related costs and benefits and other items. Segment Adjusted EBITDA is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts, and prior year financial results, providing a measure that management believes reflects core operating performance by removing the impact of transactions and events that would not be considered a part of core operations. Other companies in the industry may define segment Adjusted EBITDA differently than the Company, and as a result, it may be difficult to use segment Adjusted EBITDA, or similarly named financial measures, that other companies may use to compare the performance of those companies to the Company’s segment performance.

~~The reconciliation of income from continuing operations before income taxes to segment Adjusted EBITDA is as follows:~~

Three Months Ended

Nine Months Ended

September 30,

September 30,


2022

2021

2022

2021

Income from continuing operations before income taxes

$
(130.0)

$
84.9

$
(22.3)

$
327.1

Interest expense, net

30.4

23.0

77.7

56.6

Depreciation and amortization

45.9

49.8

147.1

111.0

Corporate Unallocated⁽²⁾

23.7

25.0

72.1

71.3

Adjusted EBITDA Addbacks⁽³⁾

17.1

15.7

103.0

102.0

Segment Adjusted EBITDA

$
(12.9)

$
198.4

$
377.6

$
668.0

~~(2)~~

~~Corporate unallocated includes corporate overhead costs and certain other income and expenses.~~

~~(3)~~

~~Adjusted EBITDA addbacks for the three and nine months ended September 30, 2022 and 2021 are as follows:~~

2825

Table of Contents

The reconciliation of income from continuing operations before income taxes to segment Adjusted EBITDA is as follows:


	Three Months Ended
	March 31,
	2023		2022
Income (loss) from continuing operations before income taxes	$	(65.6)	$	39.7
Interest expense, net		38.3		21.9
Depreciation and amortization		56.0		53.0
Corporate Unallocated⁽²⁾		26.1		26.9
Adjusted EBITDA Addbacks⁽³⁾		7.6		63.0
Segment Adjusted EBITDA	$	62.4	$	204.5

(2)

Corporate unallocated includes corporate overhead costs and certain other income and expenses.

(3)

Adjusted EBITDA addbacks for the three months ended March 31, 2023 and 2022 are as follows:


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Net gain on disposition of businesses and assets	$	—	$	—	$	(1.8)	$	(0.2)	$	—	$	(0.3)
Restructuring and other charges (Note 17)		—		0.2		(1.0)		6.8		3.7		0.4
Acquisition transaction and integration net costs (Note 3)		0.4		13.6		6.2		62.8		—		3.2
Acquisition purchase price hedge (gain) loss (Note 10)		—		—		—		22.0
Asset impairment charges or write-offs (Note 11)		1.9		1.2		3.9		3.0		0.3		0.7
European Commission request for information (Note 13)		—		—		35.6		—		—		35.6
Other items ^(a)		14.8		0.7		60.1		7.6		3.6		23.4
Total Adjusted EBITDA Addbacks	$	17.1	$	15.7	$	103.0	$	102.0	$	7.6	$	63.0

(a)

Other items for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ primarily relate to fees incurred in conjunction with certain of the Company’s strategic initiatives, as well as our transition to a new enterprise resource planning system.

NOTE 17—RESTRUCTURING

Refer to the Annual Report for further details regarding the Company’s previously announced restructuring activities included in the tables below. Restructuring charges are included within “Selling, general and administrative expenses” in the condensed consolidated statements of operations.

~~The following table provides detail of the Company’s restructuring charges for the three and nine months ended September 30, 2022 and 2021:~~

Three Months Ended

Nine Months Ended

Cumulative

September 30,

September 30,

Life-to-date

2022

2021

2022

2021

Charges

Segment

Transformational Restructuring Program

Employee termination benefits

$
—

$
0.3

$
0.1

$
6.4

$
8.8

N/A⁽¹⁾

Transformational Restructuring Program Subtotal

$
—

$
0.3

$
0.1

$
6.4

$
8.8

Other Restructurings

—

(0.1)

(1.1)

—

Various

Total Restructuring Charges

$
—

$
0.2

$
(1.0)

$
6.4

~~(1)~~

In May 2021, the Company approved a transformational restructuring program associated with the Company’s recent strategic initiatives. The Company expects to incur incremental employee termination benefit charges related to impacted employees as of September 30, 2022 of less than $1.0 million, the majority of which are expected to be paid by December 31, 2022. As this was identified as a corporate-related activity, the charges related to this restructuring program were not allocated to a specific segment, but rather included within corporate unallocated.

2926

Table of Contents

The following table provides a roll forward of the liability balances associated with the Company’s restructuring activities as of September 30, 2022. Employee termination benefit and contract termination charges are primarily recorded within “Accrued expenses and other current liabilities” in the condensed consolidated balance sheets.

Balance at





Balance at


December 31, 2021

Expenses

Deductions⁽¹⁾

September 30, 2022

Employee termination benefits

$
10.0

$
(1.4)

$
(4.4)

$
4.2

Decommissioning and other

—

0.1

(0.1)

—

Total

$
10.0

$
(1.3)

$
(4.5)

$
4.2

~~(1)~~

~~Primarily includes payments made against the existing accrual, as well as immaterial impacts of foreign currency remeasurement.~~

The following table provides detail of the Company’s restructuring charges for the three months ended March 31, 2023 and 2022:


	Three Months Ended				Cumulative
	March 31,				Life-to-date
	2023		2022		Charges		Segment
Asset Restructuring Plan⁽¹⁾
Feedstocks:
Accelerated depreciation	$	0.9	$	—	$	36.0	Feedstocks
Employee termination benefits		(0.2)		—		3.7	Feedstocks
Contract terminations		2.5		—		2.9	Feedstocks
Decommissioning and other		0.5		—		3.7	Feedstocks
Plastics Solutions:
Accelerated depreciation		—		—		1.4	Plastics Solutions
Employee termination benefits		(0.4)		—		3.0	Plastics Solutions
Decommissioning and other		0.7		—		0.7	Plastics Solutions
Engineered Materials:
Accelerated depreciation		3.1		—		6.3	Engineered Materials
Employee termination benefits		—		—		2.4	Engineered Materials
Decommissioning and other		0.6		—		4.3	Engineered Materials
Asset Restructuring Plan subtotal	$	7.7	$	—	$	64.4
Transformational Restructuring Program
Employee termination benefits	$	—	$	0.3	$	8.8
Transformational Restructuring Program Subtotal	$	—	$	0.3	$	8.8	N/A⁽²⁾
Other Restructurings		—		0.1			Various
Total Restructuring Charges	$	7.7	$	0.4

(1)

In December 2022, the Company announced an asset restructuring plan designed to reduce costs, improve profitability, reduce exposure to cyclical markets and elevated natural gas prices, and address market overcapacity. The asset restructuring plan includes (i) closure of manufacturing operations at the styrene production facility in Boehlen, Germany, (ii) closure of one of its production lines at the Stade, Germany polycarbonate plant, and (iii) closure of the PMMA sheet manufacturing site in Matamoros, Mexico. The program is expected to be substantially completed by the end of 2024. In connection with this restructuring plan, during the three months ended March 31, 2023, the Company incurred employee termination benefit charges of $(0.6) million, contract termination charges of $2.5 million, accelerated depreciation charges of $4.0 million, and decommissioning and other charges of $1.8 million. Production at all facilities have ceased and decommissioning activities are expected to continue through the end of 2024. The Company expects to incur incremental contract termination charges of $17.6 million, decommissioning and other charges of $2.2 million, as well as a limited amount of incremental employee termination benefit charges, the majority of which is expected to be paid by the end of 2024. Of the total incremental charges, $18.6 million is expected to be incurred in the Feedstocks segment, and $1.2 million is expected to be incurred in the Plastics Solution segment.

On April 4, 2023, the Company entered into an agreement to sell its land, buildings and equipment in Matamoros, Mexico for a cash consideration of approximately $19.0 million. The transaction is expected to close within the second quarter of 2023.

(2)

In May 2021, the Company approved a transformational restructuring program associated with the Company’s strategic initiatives. The Company expects to incur incremental employee termination benefit charges related to impacted employees as of March 31, 2023 of less than $1.0 million, the majority of which are expected to be paid in 2023. As this was identified as a corporate-related activity, the charges related to this restructuring program were not allocated to a specific segment, but rather included within corporate unallocated.

Table of Contents

Refer to Note 13 for further information regarding the asset retirement obligation. The following table provides a roll forward of the other liability balances associated with the Company’s restructuring activities as of March 31, 2023. Employee termination benefit and contract termination charges are primarily recorded within “Accrued expenses and other current liabilities” in the condensed consolidated balance sheets.


	Balance at						Balance at
	December 31, 2022		Expenses		Deductions⁽¹⁾		March 31, 2023
Employee termination benefits	$	13.3	$	(0.6)	$	(2.1)	$	10.6
Contract terminations		—		2.5		(2.5)		—
Decommissioning and other		—		1.8		(1.8)		—
Total	$	13.3	$	3.7	$	(6.4)	$	10.6

(1)

Primarily includes payments made against the existing accrual, as well as immaterial impacts of foreign currency remeasurement.

NOTE 18—ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The components of AOCI, net of income taxes, consisted of:


	Cumulative		Pension & Other						Cumulative		Pension & Other
	Translation		Postretirement Benefit			Cash Flow			Translation		Postretirement Benefit			Cash Flow
Three Months Ended September 30, 2022 and 2021	Adjustments		Plans, Net			Hedges, Net	Total
Balance as of June 30, 2022	$	(153.4)	$	(27.0)	$	2.5	$	(177.9)
Three Months Ended March 31, 2023 and 2022									Adjustments		Plans, Net			Hedges, Net	Total
Balance as of December 31, 2022									$	(151.2)	$	29.0	$	(9.1)	$	(131.3)
Other comprehensive income (loss)		(45.0)		2.4		(3.4)		(46.0)		10.5		—		(13.2)		(2.7)
Amounts reclassified from AOCI to net income⁽¹⁾		—		(0.9)		(2.2)		(3.1)		—		0.3		5.8		6.1
Balance as of September 30, 2022	$	(198.4)	$	(25.5)	$	(3.1)	$	(227.0)
Balance as of March 31, 2023									$	(140.7)	$	29.3	$	(16.5)	$	(127.9)

Balance as of June 30, 2021	$	(109.3)	$	(69.8)	$	(0.8)	$	(179.9)
Balance as of December 31, 2021									$	(114.3)	$	(33.6)	$	0.7	$	(147.2)
Other comprehensive income (loss)		(1.7)		9.3		0.6		8.2		(4.3)		—		0.7		(3.6)
Amounts reclassified from AOCI to net income ⁽¹⁾		—		(1.2)		0.6		(0.6)		—		0.3		0.8		1.1
Balance as of September 30, 2021	$	(111.0)	$	(61.7)	$	0.4	$	(172.3)
Balance as of March 31, 2022									$	(118.6)	$	(33.3)	$	2.2	$	(149.7)

Cumulative

Pension & Other


Translation

Postretirement Benefit

Cash Flow

Nine Months Ended September 30, 2022 and 2021

Adjustments

Plans, Net

Hedges, Net

Total

Balance as of December 31, 2021

$
(114.3)

$
(33.6)

$
0.7

$
(147.2)

Other comprehensive income (loss)

(84.1)

10.0

(2.7)

(76.8)

Amounts reclassified from AOCI to net income⁽¹⁾

—

(1.9)

(1.1)

(3.0)

Balance as of September 30, 2022

$
(198.4)

$
(25.5)

$
(3.1)

$
(227.0)

Balance as of December 31, 2020

$
(109.0)

$
(71.9)

$
(5.2)

$
(186.1)

Other comprehensive income (loss)

(2.0)

9.3

3.0

10.3

Amounts reclassified from AOCI to net income⁽¹⁾

—

0.9

2.6

3.5

Balance as of September 30, 2021

$
(111.0)

$
(61.7)

$
0.4

$
(172.3)

(1)

The following is a summary of amounts reclassified from AOCI to net income (loss) for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021:~~2022:

3028

Table of Contents


	Three Months Ended				Nine Months Ended					Three Months Ended
	September 30,				September 30,				Statements of Operations	March 31,				Statements of Operations
AOCI Components	2022		2021		2022		2021		Classification	2023		2022		Classification
Cash flow hedging items
Foreign exchange cash flow hedges	$	—	$	(0.3)	$	—	$	—	Cost of sales
Commodity cash flow hedges		(2.0)		—		(2.0)		—	Cost of sales	$	6.4	$	—	Cost of sales
Interest rate swaps		(0.2)		0.9		1.2		2.6	Interest expense, net		—		0.8	Interest expense, net
Total before tax		(2.2)		0.6		(0.8)		2.6			6.4		0.8
Tax effect		—		—		(0.3)		—	Provision for (benefit from) income taxes		(0.6)		—	Provision for (benefit from) income taxes
Total, net of tax	$	(2.2)	$	0.6	$	(1.1)	$	2.6		$	5.8	$	0.8

Amortization of pension and other postretirement benefit plan items
Prior service credit	$	(0.1)	$	(0.2)	$	(0.4)	$	(0.7)	(a)
Prior service cost (credit)										$	0.1	$	(0.1)	(a)
Net actuarial loss		0.6		1.7		2.0		5.3	(a)		0.3		0.6	(a)
Net curtailment and settlement gain		(1.4)		(2.5)		(3.3)		(2.5)	(a)
Total before tax		(0.9)		(1.0)		(1.7)		2.1			0.4		0.5
Tax effect		—		(0.2)		(0.2)		(1.2)	Provision for (benefit from) income taxes		(0.1)		(0.2)	Provision for (benefit from) income taxes
Total, net of tax	$	(0.9)	$	(1.2)	$	(1.9)	$	0.9		$	0.3	$	0.3

(a)

These AOCI components are included in the computation of net periodic benefit costs (see Note 14).

NOTE 19—EARNINGS PER SHARE

Basic earnings per ordinary share (“basic EPS”) is computed by dividing net income available to ordinary shareholders by the weighted average number of the Company’s ordinary shares outstanding for the applicable period. Diluted earnings per ordinary share (“diluted EPS”) is calculated using net income available to ordinary shareholders divided by diluted weighted average ordinary shares outstanding during each period, which includes unvested RSUs, option awards, and PSUs. Diluted EPS considers the impact of potentially dilutive securities except in periods in which there is a loss from continuing operations because the inclusion of the potential ordinary shares would have an anti-dilutive effect.

~~Table of Contents~~

The following table presents basic EPS and diluted EPS for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022.


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
(in millions, except per share data)	2022		2021		2022		2021		2023		2022
Earnings:
Net income (loss) from continuing operations	$	(117.9)	$	79.4	$	(63.7)	$	278.2	$	(48.9)	$	17.1
Net income (loss) from discontinued operations		(1.9)		13.7		(1.9)		38.0
Net loss from discontinued operations										—		(0.4)
Net income (loss)	$	(119.8)	$	93.1	$	(65.6)	$	316.2	$	(48.9)	$	16.7
Shares:
Weighted average ordinary shares outstanding		35.2		38.8		36.3		38.7		35.0		37.3
Dilutive effect of RSUs, option awards, and PSUs⁽¹⁾		—		0.7		—		0.9		—		0.8
Diluted weighted average ordinary shares outstanding		35.2		39.5		36.3		39.6		35.0		38.1
Income (loss) per share:
Income (loss) per share—basic:
Continuing operations	$	(3.35)	$	2.04	$	(1.76)	$	7.19	$	(1.40)	$	0.46
Discontinued operations		(0.06)		0.35		(0.05)		0.98		—		(0.01)
Income (loss) per share—basic	$	(3.41)	$	2.39	$	(1.81)	$	8.17	$	(1.40)	$	0.45
Income (loss) per share—diluted:
Continuing operations	$	(3.35)	$	2.01	$	(1.76)	$	7.03	$	(1.40)	$	0.45
Discontinued operations		(0.06)		0.35		(0.05)		0.96		—		(0.01)
Income (loss) per share—diluted	$	(3.41)	$	2.36	$	(1.81)	$	7.99	$	(1.40)	$	0.44

(1)

Refer to Note 15 for discussion of RSUs, option awards, and PSUs granted to certain Company directors and employees. As the Company recorded a net loss from continuing operations for the three ~~and nine~~ months ended ~~September 30, 2022,~~

Table of Contents

March 31, 2023, potential shares related to equity-based awards have been excluded from the calculation of diluted EPS, as doing so would be anti-dilutive. There were ~~0.6~~0.9 million anti-dilutive shares that have been excluded from the computation of diluted earnings per share for the three ~~and nine~~ months ended ~~September 30, 2021.~~March 31, 2022.

NOTE 20—IMPAIRMENT AND OTHER CHARGES

~~Other~~Impairment and other charges consisted of the following:


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Asset impairment charges or write-offs (Note 11)	$	1.9	$	1.2	$	3.9	$	3.0	$	0.3	$	0.7
European Commission request for information (Note 13)		—		—		35.6		—		—		35.6
Total	$	1.9	$	1.2	$	39.5	$	3.0	$	0.3	$	36.3

3230

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

~~2022~~2023 Year-to-Date Highlights

During the three ~~and nine~~ months ended ~~September 30, 2022,~~March 31, 2023, Trinseo recognized net loss from continuing operations of ~~$117.9~~$48.9 million ~~and $63.7 million, respectively,~~ and Adjusted EBITDA of ~~$(36.6) million~~$36.3 million. Continued customer destocking and ~~$305.5 million, respectively. The challenging operating conditions experienced~~underlying demand weakness from the uncertain economic and geopolitical macroenvironment originating in the ~~first~~second half of 2022 ~~continued~~drove lower sales volume and margins across all segments year-over-year. While overall demand remains constrained, especially in building & construction and consumer durables applications, the impact to our operating performance was mitigated from the asset restructuring initiatives that were announced in the ~~third~~fourth quarter ~~including the uncertain geopolitical situation, continued COVID-19 lockdowns in China,~~of 2022 as well as lower input costs and historically high natural gas and energy prices. These factors led to weaker demand and significant customer destocking which was exacerbated by a steep decline in many raw material prices throughout the third quarter, following very high raw material prices in the first half of 2022. Further, weak demand and ample supply pressured margins.commercial actions. Refer to the discussion below for further information and refer to “Non-GAAP Performance Measures” for discussion of our use of non-GAAP measures in evaluating our performance and a reconciliation of these measures.

Amid ~~these uncertain market conditions,~~this challenging environment, the Company ~~has continued~~continues to implement ~~liquidity-focused~~numerous liquidity improvement actions, including ~~reduced~~reducing working capital, ~~spending, operating expenses~~deferring capital expenditures and ~~working capital.~~reducing cash dividends. As a result of these actions, the Company achieved positive cash generation from operating activities, and ~~solid~~strong quarter-end liquidity. The Company continues to ~~maintain a strong balance sheet, has substantial sources of liquidity available,~~have access to capital resources, no maintenance covenants on our debt agreements, and no significant debt maturing until September 2024. Refer to the “Capital Resources and Liquidity” section below for further information. Other highlights for the year are described below.

~~Potential Profitability Improvement Initiatives~~

In response to the challenging macroeconomic environment that began to emerge in the first quarter of 2022, resulting in historically-low demand and high utility costs, Trinseo is evaluating its asset footprint to improve its economic position and operating flexibility. The potential initiatives under consideration include:

●

~~Closure of our Boehlen, Germany styrene plant to both improve profitability and aid in achieving our 2030 sustainability goals;~~

●

Optimization of our production and supply chain for PC and downstream PC compounds, including the potential closure of one PC production line at our Stade, Germany facility which would lower costs and greatly reduce exposure to the cyclical merchant PC market;

●

~~Restructuring of our PMMA sheets business in North America; and,~~

●

~~Capacity reduction at our SB Latex facility in Hamina, Finland starting in mid-2023 due to the current over-capacity in Europe.~~

These potential initiatives, if approved and implemented, may result in future charges including, but not limited to, impairment or accelerated depreciation of long-lived assets, employee termination benefit charges, contract termination costs, and demolition and decommissioning expenses.

~~European Commission Request for Information~~

In 2018, Trinseo received a request for information from the European Commission Directorate General for Competition (the “European Commission”) related to styrene monomer commercial activity in the European Economic Area, as well as subsequent requests for information. Trinseo has fully responded to all information requests from the European Commission and continues to fully cooperate on this matter, which remains ongoing. As a result of further developments in this matter, during the first quarter of 2022, Trinseo recorded a charge of $35.6 million which is included within “Other charges” on the condensed consolidated statements of operations. Refer to Note 13 in the condensed consolidated financial statements for more information.

~~Acquisition of Heathland~~

On January 3, 2022, the Company closed on the previously-announced acquisition of Heathland B.V. (“Heathland”) for an estimated purchase price of $29.3 million, including an initial cash purchase price of $22.9 million, as well as $6.4 million of contingent cash consideration, representing the fair value of certain earn-out payments (the “Heathland Acquisition”). Heathland is based in Utrecht, the Netherlands, and is focused on converting post-consumer and post-industrial PMMA, PC, ABS, polystyrene, and other thermoplastic waste for use in a wide range of high-end applications. The acquisition of Heathland is consistent with Trinseo’s strategy and enhances our footprint as a sustainable solutions provider. Refer to Note 3 in the condensed consolidated financial statements for more information.

~~Table of Contents~~

~~Process Pause~~Restarting Exploration for Divestiture of Styrenics Business

In November 2021, the Company announced that it had begun work to explore the divestiture of our styrenics business and subsequently launched a formal sales process in the first quarter of ~~2022.~~2022, which was paused in July 2022 as a result of the deterioration of financing markets and the geopolitical economic uncertainty, particularly in the European energy markets. The Company is restarting the sales process due to interest from third parties for all or part of the business. The scope of the potential divestiture ~~was~~is expected to include the Feedstocks and Polystyrene reporting segments as well as our 50% ownership of Americas ~~Styrenics. While this process generated broad~~Styrenics, and ~~significant interest from both strategic~~will include marketing individual assets and ~~financial parties,~~regional businesses as needed in order to ensure the ~~deterioration of financing markets and the economic uncertainty created by the war in Ukraine, particularly in European energy markets, has impeded the Company’s ability to obtain~~Company obtains full value for the styrenics business. As

Sale of Matamoros, Mexico Manufacturing Facility

On April 4, 2023, Trinseo entered into an agreement to sell its land, buildings and equipment at its PMMA sheet manufacturing facility in Matamoros, Mexico for a ~~result,~~cash consideration of approximately $19.0 million. The transaction is expected to close within the ~~Company has decided to pause the sale process.~~

second quarter of 2023. This pause does not change the Company’s transformation strategy of becoming a higher growth, higher margin, and less volatile specialty material and sustainable solutions provider. The Company intends to reevaluate a potential salesite was part of the ~~styrenics~~previously-announced asset restructuring plan approved in the fourth quarter of 2022 to consolidate our sheet manufacturing business ~~when macroeconomic conditions improve.~~and optimize our resources.

Bristol Spill

On March 24, 2023, due to equipment failure at the Bristol, Pennsylvania facility, operated by our wholly-owned subsidiary, Altuglas LLC, an accidental release of a latex emulsion product occurred, which ultimately flowed into a local waterway (the “Bristol Spill”). We reported the event and cooperated closely with local, state, and federal authorities on the response activities. Water sampling conducted by the authorities did not detect site-related material in the waterway. The safety of our employees, our communities and our environment are a top priority, and we are committed to operate safely and without disturbance to our community. Refer to Note 13 in our condensed consolidated financial statements for additional information related to this matter.

Table of Contents

Results of Operations

Results of Operations for the Three ~~and Nine~~ Months Ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~


	Three Months Ended								Nine Months Ended								Three Months Ended
	September 30,								September 30,								March 31,
(in millions)	2022		%		2021		%		2022		%		2021		%		2023		%		2022		%
Net sales	$	1,178.1	100	%	$	1,269.3	100	%	$	3,990.3	100	%	$	3,529.0	100	%	$	996.3	100	%	$	1,386.7	100	%
Cost of sales		1,217.6	103	%		1,101.0	87	%		3,714.8	93	%		2,951.7	84	%		959.1	96	%		1,210.7	87	%
Gross profit (loss)		(39.5)	(3)	%		168.3	13	%		275.5	7	%		577.3	16	%
Gross profit																		37.2	4	%		176.0	13	%
Selling, general and administrative expenses		80.5	7	%		76.4	6	%		262.8	7	%		230.4	7	%		84.7	9	%		96.7	7	%
Equity in earnings of unconsolidated affiliates		22.8	2	%		17.1	1	%		83.8	2	%		70.2	2	%		17.6	2	%		21.6	2	%
Other charges		1.9	—	%		1.2	—	%		39.5	1	%		3.0	—	%
Impairment and other charges																		0.3	—	%		36.3	3	%
Operating income (loss)		(99.1)	(8)	%		107.8	8	%		57.0	1	%		414.1	11	%		(30.2)	(3)	%		64.6	5	%
Interest expense, net		30.4	3	%		23.0	2	%		77.7	2	%		56.6	2	%		38.3	4	%		21.9	2	%
Acquisition purchase price hedge loss		—	—	%		—	—	%		—	—	%		22.0	1	%
Other expense (income), net		0.5	—	%		(0.1)	—	%		1.6	—	%		8.4	—	%		(2.9)	—	%		3.0	—	%
Income (loss) from continuing operations before income taxes		(130.0)	(11)	%		84.9	6	%		(22.3)	(1)	%		327.1	8	%		(65.6)	(7)	%		39.7	3	%
Provision for (benefit from) income taxes		(12.1)	(1)	%		5.5	—	%		41.4	1	%		48.9	1	%		(16.7)	(2)	%		22.6	2	%
Net income (loss) from continuing operations	$	(117.9)	(10)	%	$	79.4	6	%	$	(63.7)	(2)	%	$	278.2	7	%	$	(48.9)	(5)	%	$	17.1	1	%
Net income (loss) from discontinued operations, net of income taxes		(1.9)	—	%		13.7	1	%		(1.9)	—	%		38.0	1	%
Net loss from discontinued operations, net of income taxes																		—	—	%		(0.4)	—	%
Net income (loss)	$	(119.8)	(10)	%	$	93.1	7	%	$	(65.6)	(2)	%	$	316.2	8	%	$	(48.9)	(5)	%	$	16.7	1	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

Net Sales

Net sales decreased 7%28% year-over-year. Lower sales volumes resulted in ~~an 18%~~a 20% decrease ~~as economic uncertainty and falling raw material prices led to a high level of~~from continued customer destocking and ~~depressed~~underlying demand weakness from an uncertain economic and geopolitical macroenvironment, particularly in applications supporting building & construction and consumer durables. ~~This~~Additionally, a decrease of 7% was ~~partially offset by an 11% increase in net sales from higher~~related to lower selling prices ~~mainly due to~~from the pass through of ~~higher~~lower raw material ~~and utility~~ costs.

~~Table of Contents~~

Cost of Sales

The ~~11% increase~~21% decrease in cost of sales was primarily attributable to ~~an 18% increase in raw material costs, which included~~ a one-time charge of $22.5 million related to raw material contract obligations and inventory writedowns. Also contributing to the increase was a 6% increase related to higher utility costs. Partially offsetting these increases was a17% decrease ~~of 14%~~ due to lower sales ~~volumes.~~volumes and a 9% decrease in raw material costs. Natural gas hedges contributed to an $18.8 million unfavorable impact year-over-year.

Gross Profit

The decrease in gross profit of ~~123%~~79% was primarily attributable to lower ~~margins compared to the very high levels observed in the third quarter of 2021 in various segments,~~sales volumes as discussed above as well as lower ~~sales volume~~margins from weaker market conditions including low demand and ~~one-time headwinds~~available supply. Margins were also pressured by unfavorable impacts from natural gas hedges as discussed above. See the segment discussion below for further information.

Selling, General and Administrative Expenses (SG&A)

The ~~$4.1~~$12.0 million, or 5%12%, ~~increase~~decrease in SG&A was primarily due to ~~an increase~~a decrease of ~~$12.3~~$17.7 million in costs associated with the Company’s strategic initiatives, including the exploration of a potential divestiture of our styrenics business, ~~and~~ a ~~$0.9 million increase in bad debt expense. Offsetting these increased costs was a $9.7~~$3.1 million decrease in acquisition transaction and integration costs, ~~compared to~~and a $2.1 million decrease in costs incurred in connection with the ~~prior year.~~Company’s enterprise resource planning system upgrade. Offsetting these decreased costs was a $3.3 million increase in restructuring costs, driven by the asset restructuring plan approved in the fourth quarter of 2022, a $3.1 million increase in depreciation expense, and a $1.6 million increase in travel-related expenses.

Table of Contents

Equity in Earnings of Unconsolidated Affiliates

The ~~increase~~decrease in ~~equity earnings of $5.7 million was due to higher~~ equity earnings from Americas Styrenics of $4.0 million was due to ~~stronger~~lower styrene margin which was partially offset by higher polystyrene ~~margins. Equity earnings in the prior year were also negatively impacted by headwinds from production issues caused by Hurricane Ida.~~margin.

Impairment and Other Charges

During the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ the Company recorded impairment charges of ~~$1.9~~$0.3 million and ~~$0.3~~$0.7 million, respectively, related to our Boehlen styrene monomer assets, as described within Note 11 in the condensed consolidated financial statements. Additionally, during the three months ended ~~September 30, 2021,~~March 31, 2022, the Company recorded ~~impairment charges~~an estimated liability of ~~$0.9~~$35.6 million related to ~~certain long-lived assets~~the European Commission request for information, as described within Note 13 in ~~our Base Plastics segment.~~the condensed consolidated financial statements.

Interest Expense, Net

The increase in interest expense, net of ~~$7.4~~$16.4 million, or ~~32%~~75%, was primarily attributable to the increase in the LIBO rate year-over-year. Refer to Note 8 in the condensed consolidated financial statements for further information.

Other Expense (Income), Net

Other ~~expense,~~income, net for the three months ended ~~September 30, 2022~~March 31, 2023 was ~~$0.5~~$2.9 million, which included an $0.8 million gain on extinguishment of debt recorded in relation to the repurchase of $3.0 million of the 2029 Senior Notes in the open market, and a $0.4 million gain related to the non-service cost components of net periodic benefit cost which were more than offsetwas primarily driven by foreign exchange transaction ~~losses~~gains of ~~$1.7~~$2.7 million. These net foreign exchange transaction ~~losses~~gains included ~~$35.4~~$10.5 million of ~~losses~~gains primarily from the remeasurement of our euro-denominated payables due to the relative changes in rates between the U.S. dollar and the euro during the period, partially offset by ~~$33.7~~$7.8 million of ~~gains~~losses from our foreign exchange forward contracts.

Other ~~income,~~expense, net for the three months ended ~~September 30, 2021~~March 31, 2022 was ~~$0.1~~$3.0 million, which included a ~~$1.1~~$1.2 million of ~~benefit~~expense related to the non-service cost components of net periodic benefit cost ~~partially offset by~~as well as foreign exchange transaction losses of ~~$0.4~~$1.4 million. These net foreign exchange transaction losses included ~~$23.7~~$10.2 million of ~~foreign exchange transaction~~ losses primarily from the remeasurement of our euro denominated payables due to the relative changes in rates between the U.S. dollar and the euro during the period, ~~almost entirely~~partially offset by ~~$23.3~~$8.8 million of gains from our foreign exchange forward contracts.

~~Table of Contents~~

Provision for (Benefit from) Income Taxes

Benefit from income taxes for the three months ended ~~September 30, 2022~~March 31, 2023 totaled ~~$12.1~~$16.7 million, resulting in an effective tax rate of ~~9.3%~~25.4%. Provision for income taxes for the three months ended ~~September 30, 2021~~March 31, 2022 totaled ~~$5.5~~$22.6 million, resulting in an effective tax rate of ~~6.5%~~56.9%.

The decrease in provision for income taxes is primarily driven by the decrease of ~~$214.9~~$105.3 million in income from continuing operations before income taxes.

The provision for income taxes for the three months ended September 30, 2021 was also impacted by the release of a valuation allowance of $16.3 million in the third quarter of 2021, as a result of improvements in actual business operations and projected future results of one of the Company’s subsidiaries in China.

Net Income (Loss) from Discontinued Operations, Net of Income Taxes

Net income (loss) from discontinued operations, net of income taxes during the three months ended ~~September 30,~~March 31, 2022 ~~and 2021~~ was ~~$(1.9)~~$(0.4) million, ~~and $13.7 million, respectively,~~ and was related ~~the results and sale of our Synthetic Rubber business. Refer~~ to ~~Note 4 in the condensed consolidated financial statements for further information.~~

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

~~Net Sales~~

Of the 13% increase in net sales, 16% was attributable to increased selling prices, mainly due to the pass through of higher raw material costs, such as styrene, along with higher energy costs. An additional 10% increase was due to the contributions from our acquisitions in 2021, including the PMMA Acquisition, which closed on May 3, 2021, and the Aristech Surfaces Acquisition, which closed on September 1, 2021. These increases were partially offset by an 11% decrease due to lower volumes across all segments due to weakening demand in several applications, including third quarter customer destocking, particularly in Europe, as well as the impacts of COVID-19 in China.

~~Cost of Sales~~

The 26% increase in cost of sales was primarily attributable to a 21% increase in raw material costs, which included a one-time charge of $22.5 million related to raw material contract obligations and inventory writedowns. Also contributing was an 11% increase related to the PMMA Acquisition and Aristech Surfaces Acquisition. Partially offsetting these increases was a decrease of 9% due to lower volumes.

~~Gross Profit~~

The decrease in gross profit of 52% was primarily attributable to lower margins compared to the very high levels observed in the first three quarters of 2021 in Feedstocks, Base Plastics, and Polystyrene, as well as lower sales volume as described above. These impacts were partially offset by additional gross profit from the 2021 acquisitions. See the segment discussion below for further information.

~~Selling, General and Administrative Expenses (SG&A)~~

The $32.4 million, or 14%, increase in SG&A was primarily due to an increase of $57.0 million in costs associated with the Company’s strategic initiatives, including the exploration of a potential divestiture of our styrenics business, a $3.0 million increase in costs incurred in connection with the Company’s enterprise resource planning system upgrade, a $6.1 million increase in employee compensation, and a $4.0 million increase in bad debt expense. Offsetting these costs was a decrease of $43.0 million related to acquisition transaction and integration costs incurred, primarily in connection with the PMMA Acquisition.

~~Equity in Earnings of Unconsolidated Affiliates~~

The increase in equity earnings of $13.6 million was due to higher equity earnings from Americas Styrenics due mainly to higher styrene profitability, which was partially offset by lower sales volume that resulted from styrene production outages and a weaker demand environment including limited export opportunities.

~~Table of Contents~~

~~Other Charges~~

During the nine months ended September 30, 2022, the Company recorded a charge of $35.6 million related to the European Commission request for information, as described within Note 13 in the condensed consolidated financial statements. The Company also recorded impairment charges of $3.9 million and $2.1 million related to our Boehlen styrene monomer assets during the nine months ended September 30, 2022 and 2021, respectively, as described within Note 11 in the condensed consolidated financial statements. Additionally, during the nine months ended September 30, 2021, the Company recorded $0.9 million of impairment charges on certain long-lived assets in our Base Plastics segment.

~~Interest Expense, Net~~

The increase in interest expense, net of $21.1 million, or 37%, was primarily attributable to the Company’s issuance of the 2029 Senior Notes, which were not issued until late in the first quarter of 2021 and the 2028 Term Loan B, issued in the second quarter of 2021. Refer to Note 8 in the condensed consolidated financial statements for further information.

~~Acquisition Purchase Price Hedge Loss~~

The $22.0 million acquisition purchase price hedge loss for the nine months ended September 30, 2021 was due to the change in fair value of the Company’s forward currency hedge arrangement on the euro-denominated purchase price of the PMMA business.

~~Other Expense, Net~~

Other expense, net for the nine months ended September 30, 2022 was $1.6 million, which included foreign exchange transaction losses of $1.8 million. These net foreign exchange transaction losses included $83.4 million of losses primarily from the remeasurement of our euro-denominated payables due to the relative changes in rates between the U.S. dollar and the euro during the period, partially offset by $81.6 million of gains from our foreign exchange forward contracts. These losses were partially offset by an $0.8 million gain on extinguishment of debt recorded in relation to the repurchase of $3.0 million of the 2029 Senior Notes in the open market.

Other expense, net for the nine months ended September 30, 2021 was $8.4 million, which included $2.3 million of expense related to the non-service cost components of net periodic benefit cost and $4.5 million of transfer taxes associated with the PMMA Acquisition. These expense amounts were partially offset by foreign exchange transaction gains of $0.4 million, which included $43.0 million of foreign exchange transaction losses primarily from the remeasurement of our euro denominated payables due to the relative changes in rates between the U.S. dollar and the euro during the period, offset by $43.4 million of gains from our foreign exchange forward contracts, excluding the acquisition purchase price hedge.

~~Provision for Income Taxes~~

Provision for income taxes for the nine months ended September 30, 2022 totaled $41.4 million, resulting in an effective tax rate of (185.2)%. Provision for income taxes for the nine months ended September 30, 2021 totaled $48.9 million, resulting in an effective tax rate of 14.9%.

The decrease in the provision for income taxes is primarily driven by the decrease of $349.4 million in income from continuing operations before income taxes. Also decreasing the provision for income taxes was the release of a valuation allowance of $8.5 million during the second quarter of 2022, as a result of improvements in actual and projected future results in one of the Company’s subsidiaries in Luxembourg. This benefit was more than offset by the revaluation of the Company’s net deferred tax assets in Switzerland, which were originally established as part of the Swiss cantonal tax reform measures enacted in 2019. This revaluation resulted in a one-time deferred tax expense of $15.3 million recorded in the second quarter of 2022.

The provision for income taxes for the nine months ended September 30, 2021 was also impacted by the release of a valuation allowance of $16.3 million in the third quarter of 2021, as a result of improvements in actual business operations and projected future results of one of the Company’s subsidiaries in China.

~~Table of Contents~~

~~Net Income (Loss) from Discontinued Operations, Net of Income Taxes~~

~~Net income (loss) from discontinued operations, net of income taxes during the nine months ended September 30, 2022 and 2021 was $(1.9) million and $38.0 million, respectively, and was related~~ the results and sale of our Synthetic Rubber business. Refer to Note 4 in the condensed consolidated financial statements for further information.

Outlook

While some of the challenging operating conditions from the second half of 2022 have persisted into the beginning of 2023, such as customer destocking ~~is expected~~and underlying demand weakness, we have seen a meaningful decrease in European natural gas prices and, with the removal of COVID-related restrictions in China, more limited arbitrage opportunities for lower-cost standard grade products to ~~continue through~~enter Europe from Asia. Despite continued demand weakness, we expect improved profitability from higher margins, as a result of moderating input costs and pricing initiatives, as well as cost savings from our previously announced asset restructuring initiatives. We expect additional improvement in the ~~remainder~~second quarter and the rest of the year ~~we expect sequential earnings improvement in~~from lower input and other costs, with a gradual demand increase through the ~~fourth quarter. One-time headwinds from~~end of the ~~third quarter, including~~year. Market recovery and natural gas hedges remain a ~~large negative net timing impact from falling raw material prices,~~headwind, although natural gas hedge losses are ~~not~~ expected to ~~repeat in the fourth quarter. In addition, we are evaluating potential asset optimization initiatives, such~~decrease as ~~the potential closures~~current forward rates stabilize.

Table of ~~the Boehlen, Germany styrene plant and one production line at the Stade, Germany polycarbonate plant, which would be expected to have a positive financial impact in 2023.~~Contents

~~Through this market volatility and uncertainty, the~~The Company has ~~continued to maintain a strong financial position with ample~~ access to capital resources and continues to focus on liquidity improvement actions to manage the anticipated impact of the challenging macroeconomic environment on our business operations for the foreseeable future. ~~We expect~~The profitability improvement factors noted above, coupled with certain cash preservation initiatives that we have undertaken, such as a reduction in working capital, capital expenditure deferments, and a planned further substantial reduction to ~~end the year with a strong~~our cash dividend, will strengthen our liquidity and balance sheet and ~~liquidity~~are expected to position ~~which will enable~~ us to ~~continue investing in sustainability and organic growth opportunities while providing shareholder return.~~deliver sustained financial strength.

Selected Segment Information

The following sections describe net sales, Adjusted EBITDA, and Adjusted EBITDA margin by segment for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022. Inter-segment sales have been eliminated. Refer to Note 16 in the condensed consolidated financial statements for further information on our segments, as well as for a detailed definition of Adjusted EBITDA and a reconciliation of income from continuing operations before income taxes to segment Adjusted EBITDA.

Engineered Materials Segment

Our Engineered Materials segment consists of rigid thermoplastic compounds and blends products sold into high growth and high value applications in markets such as consumer electronics and medical, as well as soft thermoplastic elastomers (“TPEs”) products which are sold into markets such as footwear and automotive. The Engineered Materials segment also includes polymethyl methacrylates (“PMMA”) and activated methyl methacrylates (“MMA”) products, which are sold into a variety of applications including automotive, building & construction, medical, consumer electronics, and wellness, among others.


	Three Months Ended								Nine Months Ended								Three Months Ended
	September 30,								September 30,								March 31,
($ in millions)	2022			2021			% Change		2022			2021			% Change		2023			2022			% Change
Net sales	$	242.7		$	230.8		5	%	$	839.2		$	477.5		76	%	$	206.2		$	295.2		(30)	%
Adjusted EBITDA	$	7.5		$	32.7		(77)	%	$	76.2		$	68.5		11	%	$	(11.7)		$	34.7		(134)	%
Adjusted EBITDA margin		3	%		14	%				9	%		14	%				(6)	%		12	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

The ~~5% increase~~30% decrease in net sales was primarily attributable to the contribution from the Aristech Surfaces acquisition, which led to an increase of 11% year-over-year. In addition, sales price, primarily from the pass through of higher raw materials and energy costs, increased net sales by 8%. These increases were partially offset by a ~~13%~~23% decrease due to lower sales volumes from ~~reduced~~weak underlying demand ~~primarily~~and continued customer destocking, particularly in building & construction, consumer electronics, and wellness ~~and automotive~~ applications. Lower pricing also contributed to a 6% decrease year-over-year.

The ~~$25.2~~$46.4 million, or ~~77%~~134%, decrease in Adjusted EBITDA was primarily due to a decrease of ~~$18.3~~$18.0 million, or ~~56%~~52%, due to lower sales volumes ~~from reduced demand, including impacts from geopolitical uncertainty~~as described above. Lower margins resulted in ~~Europe. In addition to lower sales volume, reduced demand led to lower margins~~a decrease of $24.7 million, or 71%, due to ~~weak supply and demand dynamics and the inability~~

~~Table of Contents~~

~~to fully pass through significantly higher~~weaker MMA market conditions, as well as a $9.6 million unfavorable impact from natural gas ~~costs in Europe.~~hedges. Higher fixed costs also resulted in a ~~$6.9~~$6.1 million, or ~~21%~~18%, decrease in Adjusted ~~EBITDA.~~

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

The 76% increase in net sales was primarily attributable to the contribution from the PMMA business and the Aristech Surfaces acquisitions, which led to a 75% increase year-over-year. In addition, sales price, primarily from the pass through of higher raw materials and energy costs, increased net sales by 13%. These increases were partially offset by a decrease of 11% from lower sales volumes, as demand declined from very high levels in the prior year and also from COVID-19 lockdowns in China and geopolitical uncertainty in Europe in the current year.

~~Adjusted~~ EBITDA increased $7.7 million, or 11%, year-over-year. Our recent acquisitions of the PMMA business and Aristech Surfaces contributed a $52.3 million, or 76%, increase from the prior year. This increase was partially offset by a $10.2 million, or 15%, decrease due to lower sales volume as described above. In addition, lower margins contributed a $27.9 million, or 41%, decrease due to lower demand and higher supply. One-time charges also negatively impacted margins, including a $4.0 million charge related to a contract review with a significant supplier.manufacturing cost under absorption.

Latex Binders Segment

Our Latex Binders segment produces styrene-butadiene latex (“SB latex”) and other latex polymers and binders primarily for coated paper and packaging board, carpet and artificial turf backings, as well as a broad range of

Table of Contents

performance latex binders products, including SB latex, styrene-acrylate latex (“SA latex”), and vinylidene chloride latex for coatings, adhesives, sealants, and elastomers (“CASE”) applications.


	Three Months Ended								Nine Months Ended								Three Months Ended
	September 30,								September 30,								March 31,
($ in millions)	2022			2021			% Change		2022			2021			% Change		2023			2022			% Change
Net sales	$	340.9		$	315.6		8	%	$	1,001.3		$	877.6		14	%	$	248.1		$	306.7		(19)	%
Adjusted EBITDA	$	31.0		$	37.1		(16)	%	$	90.6		$	86.2		5	%	$	26.0		$	30.2		(14)	%
Adjusted EBITDA margin		9	%		12	%				9	%		10	%				10	%		10	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

The ~~8% increase~~19% decrease in net sales was primarily due to a ~~19% increase~~14% decrease due to lower sales volumes across all regions and applications and a 3% decrease in pricing from the pass through of lower raw material ~~costs and pricing actions, which more than offset a 4% decrease due to foreign exchange rate impacts and a 6% decrease due to lower sales volumes, mainly in carpet and construction applications.~~costs.

The ~~$6.1~~$4.2 million, or ~~16%~~14%, decrease in Adjusted EBITDA was primarily due to a decrease of ~~$5.4~~$10.6 million, or ~~15%~~35%, from lower sales volumes from customer destocking and reduced demand in ~~carpet and~~building & construction applications, in addition to a decrease of ~~$3.9~~$0.8 million, or ~~10%~~3%, due to ~~higher fixed costs.~~unfavorable foreign exchange rate impacts. These decreases were partially offset by a ~~$4.2~~$7.5 million, or ~~11%~~25%, increase attributable to higher margins from favorable ~~net timing and~~ pricing ~~actions.~~initiatives.

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

The 14% increase in net sales was primarily due to a 22% increase in pricing from the pass through of raw material costs, slightly offset by a 4% decrease due to foreign exchange rate impacts and a 4% decrease due to lower sales volumes mainly in carpet and construction applications.

The $4.4 million, or 5%, increase in Adjusted EBITDA was primarily due to an increase of $23.8 million, or 28%, attributable to higher margins which was a result of favorable net timing and pricing actions. This increase was largely offset by a $6.7 million, or 8%, decrease from lower sales volumes, a $7.2 million, or 8%, decrease due to foreign exchange rate impacts, and a $7.5 million, or 9%, decrease due to higher fixed costs.

~~Table of Contents~~

~~Base~~ Plastics Solutions Segment

~~Our~~On January 1, 2023, the Base Plastics segment was renamed to Plastics Solutions. Our Plastics Solutions segment consists of a variety of compounds and blends, the majority of which are for automotive applications. The segment also includes our acrylonitrile-butadiene-styrene (“ABS”), styrene-acrylonitrile (“SAN”), and polycarbonate (“PC”) businesses. The ~~Base~~ Plastics Solutions segment also includes the results of Heathland, which was acquired in the first quarter of 2022. However, this did not have a material impact on sales or Adjusted EBITDA for the period.


	Three Months Ended								Nine Months Ended								Three Months Ended
	September 30,								September 30,								March 31,
($ in millions)	2022			2021			% Change		2022			2021			% Change		2023			2022			% Change
Net sales	$	293.4		$	393.3		(25)	%	$	1,051.8		$	1,119.3		(6)	%	$	289.9		$	396.5		(27)	%
Adjusted EBITDA	$	(14.9)		$	87.9		(117)	%	$	99.8		$	235.0		(58)	%	$	25.6		$	68.6		(63)	%
Adjusted EBITDA margin		(5)	%		22	%				9	%		21	%				9	%		17	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

Net sales decreased by ~~25%~~27% year-over-year, primarily due to lower sales volume ~~mainly~~which contributed a 20% decrease. Sales volumes were primarily impacted by a decrease in ~~ABS~~polycarbonate from the announced shutdown of one production line as ~~a result of weaker demand for applications supporting~~well as in copolymers in building & construction, industrial, and consumer durables ~~which contributed~~applications, partially offset by higher volumes to ~~a 27% decrease.~~automotive applications. Also contributing to the overall decrease was ~~unfavorable foreign exchange rate impacts of 4%. These decreases were slightly offset by~~ a 5% ~~increase~~decrease from ~~higher~~lower pricing due to the pass through of lower raw material ~~cost.~~costs.

The ~~$102.8~~$43.0 million, or ~~117%~~63%, decrease in Adjusted EBITDA was primarily due to lower sales volumes and margins. Lower sales volumes, as described above, contributed to a ~~$38.2~~$20.7 million, or ~~44%~~30%, decrease in Adjusted EBITDA. In addition, Adjusted EBITDA decreased by ~~$60.2~~$16.0 million, or ~~69%~~23%, due to ~~a margin decline from higher raw material and utility costs, weaker demand, and increased cost competition from improved supply and~~ lower ~~cost imports of~~margins in polycarbonate and ABS ~~into Europe. In addition, higher~~products from weaker market conditions. Higher fixed costs also ~~attributed to~~contributed a ~~$5.2~~$4.4 million, or 6%, decrease in Adjusted EBITDA. Volumes supporting automotive applications improved 6% versus prior year, mainly from Europe and North America, as production and supply chain constraints eased.

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

Net sales decreased by 6% year-over-year. Lower sales volume from weaker demand for building & construction and consumer durable applications led to a 17% decrease, as well as a 4% decrease due to foreign exchange rate impacts. These were partially offset by higher pricing from the pass through of higher raw material costs which led to a 15% increase in net sales from the prior year.

The $135.2 million, or 58%, decrease in Adjusted EBITDA was primarily due to lower sales volume of $62.9 million, or 27%, and lower margins of $51.0 million, or 22%, as described above. Also contributing to the decrease was unfavorable foreign exchange rate impacts of $10.0 million, or 4%, and a decrease of $12.2 million, or 5%, due to higher fixed costs.

Polystyrene Segment

Our product offerings in our Polystyrene segment include a variety of general purpose polystyrenes (“GPPS”) and polystyrene that has been modified with polybutadiene rubber to increase its impact resistant properties (“HIPS”). These products provide customers with performance and aesthetics at a low cost across applications, including appliances,

Table of Contents

packaging, including food packaging and food service disposables, consumer electronics, and building and construction materials.

Three Months Ended

Nine Months Ended

September 30,

September 30,

($ in millions)


2022


2021


% Change

2022


2021

% Change

Net sales

$
247.7


$
274.8


(10)
%

$
877.7


$
855.0


3
%
Adjusted EBITDA

$
18.7

$
51.2

(63)
%

$
87.0

$
149.6


(42)
%
Adjusted EBITDA margin

8
%

19
%

10
%

17
%

~~Table of Contents~~


	Three Months Ended
	March 31,
($ in millions)	2023			2022			% Change
Net sales	$	209.1		$	318.0		(34)	%
Adjusted EBITDA	$	15.7		$	45.3		(65)	%
Adjusted EBITDA margin		8	%		14	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

Net sales decreased by ~~10%~~34% year-over-year. Lower sales volumes ~~including customers destocking amid falling raw material prices,~~due to weaker demand in appliance and building & construction applications led to a ~~20%~~22% decrease in net sales from the prior year. ~~This~~Also contributing to the overall decrease was ~~offset by~~a 10% ~~increase~~decrease from ~~higher~~lower pricing, primarily from the pass through of ~~higher~~lower styrene costs.

The ~~$32.5~~$29.6 million, or ~~63%~~65%, decrease in Adjusted EBITDA was primarily due to weaker demand which negatively impacted volumes and margins, particularly in building & construction and appliance applications. This resulted in a decrease of ~~$13.0~~$13.1 million, or ~~25%~~29%, due to lower volumes, and a decrease of ~~$19.3~~$17.7 million, or ~~38%~~39%, due to lower margins. ~~Additionally, a decrease of $3.6 million, or 7%, was due to higher fixed costs.~~

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

~~The 3% increase in net sales was due to higher pricing primarily from the pass through of higher styrene costs, which led to~~These decreases were partially offset by an increase of ~~10% increase in net sales compared to the prior year. Slightly offsetting this increase was a 7% decrease due to lower sales volume as described above.~~

~~The $62.6~~$1.8 million, or ~~42%, decrease in Adjusted EBITDA was due to a decrease of $47.6 million, or 32%~~4%, from lower ~~margins primarily from weaker demand as well as new supply in China. In addition, a decrease of $17.3 million, or 12%, was due to lower volumes.~~fixed costs.

Feedstocks Segment

The Feedstocks segment includes the Company’s production and procurement of styrene monomer outside of North America, which is used as a key raw material for the production of polystyrene, expandable polystyrene, SAN resins, SA latex, SB latex, ABS resins, and unsaturated polyethylene ~~resins, and styrene-butadiene rubber.~~resins.

	��
		Three Months Ended								Nine Months Ended								Three Months Ended
		September 30,								September 30,								March 31,
($ in millions)		2022			2021			% Change		2022			2021			% Change		2023			2022			% Change
Net sales		$	53.4		$	54.8		(3)	%	$	220.3		$	199.6		10	%	$	43.0		$	70.3		(39)	%
Adjusted EBITDA		$	(78.0)		$	(27.6)		183	%	$	(59.8)		$	58.5		(202)	%	$	(10.8)		$	4.1		(363)	%
Adjusted EBITDA margin			(146)	%		(50)	%				(27)	%		29	%				(25)	%		6	%

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

Net sales decreased 3%39% year-over-year. Lower styrene-related sales volume resulted in a ~~24%~~19% decrease ~~which was partially offset by~~along with a ~~22% increase~~17% decrease due to ~~higher styrene prices.~~lower pricing.

The decrease of ~~$50.4~~$14.9 million in Adjusted EBITDA was primarily attributed to a ~~$59.0~~$15.4 million, or ~~214%~~379%, decrease ~~due to~~from lower styrene margins, including impacts from ~~elevated utility costs caused by historically high natural gas prices in Europe, weaker demand, and~~a $7.3 million unfavorable net ~~timing. In addition, a decrease~~timing variance. The styrene plant in Terneuzen, the Netherlands was restarted in late January 2023 and, as part of ~~$5.5 million, or 20%,~~our asset restructuring plan, the Boehlen, Germany styrene plant was ~~due to higher fixed costs. Slightly offsetting these decreases was an increase of $14.1 million, or 51%, due to foreign exchange impacts.~~permanently closed in December 2022.

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

~~Net sales increased 10% year-over-year. Higher styrene prices resulted in a 29% increase in net sales, which was partially offset by an 18% decrease due to lower styrene-related sales volume.~~

The decrease of $118.3 million in Adjusted EBITDA was primarily attributed to a $134.8 million, or 231%, decrease due to lower styrene margins including impacts from higher utility costs caused by a rise in natural gas prices in Europe and weaker demand. Slightly offsetting this decrease was an increase of $20.6 million, or 35%, due to foreign exchange rate impacts.

Americas Styrenics Segment

This segment consists solely of the equity earnings from of our 50%-owned joint venture, Americas Styrenics, a producer of both styrene monomer and polystyrene in North America. Styrene monomer is a basic building block of

~~Table of Contents~~

plastics and a key input to many of the Company’s products, as well as a key raw material for the production of polystyrene. Major applications for the polystyrene products Americas Styrenics produces include appliances, food packaging, food service disposables, consumer electronics, and building and construction materials.


	Three Months Ended						Nine Months Ended						Three Months Ended
	September 30,						September 30,						March 31,
($ in millions)	2022		2021		% Change		2022		2021		% Change		2023		2022		% Change
Adjusted EBITDA*	$	22.8	$	17.1	33	%	$	83.8	$	70.2	19	%	$	17.6	$	21.6	(19)	%

Table of Contents

*The results of this segment are comprised entirely of earnings from Americas Styrenics, our equity method investment. As such, Adjusted EBITDA related to this segment is included within “Equity in earnings of unconsolidated affiliates” in the condensed consolidated statements of operations.

Three Months Ended – ~~September 30,~~March 31, 2023 vs. March 31, 2022 ~~vs. September 30, 2021~~

The ~~increase~~decrease in Adjusted EBITDA was mainly due to ~~higher margins~~lower styrene margin which ~~were~~was partially offset by ~~lower volumes. Prior period included headwinds from production issues caused by Hurricane Ida.~~

~~Nine Months Ended – September 30, 2022 vs. September 30, 2021~~

~~The increase in Adjusted EBITDA was due to~~ higher ~~margins, including a stronger styrene spot market, which were partially offset by lower volumes.~~polystyrene margin.

Non-GAAP Performance Measures

We present Adjusted EBITDA as a non-GAAP financial performance measure, which we define as income from continuing operations before interest expense, net; provision for income taxes; depreciation and amortization expense; loss on extinguishment of long-term debt; asset impairment charges; gains or losses on the dispositions of businesses and assets; restructuring charges; acquisition related costs and other items. In doing so, we are providing management, investors, and credit rating agencies with an indicator of our ongoing performance and business trends, removing the impact of transactions and events that we would not consider a part of our core operations.

There are limitations to using the financial performance measures such as Adjusted EBITDA. This performance measure is not intended to represent net income or other measures of financial performance. As such, it should not be used as an alternative to net income as an indicator of operating performance. Other companies in our industry may define Adjusted EBITDA differently than we do. As a result, it may be difficult to use this or similarly-named financial measures that other companies may use, to compare the performance of those companies to our performance. We compensate for these limitations by providing a reconciliation of this performance measure to our net income, which is determined in accordance with GAAP.

~~Table of Contents~~

Adjusted EBITDA is calculated as follows for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021:~~2022:


	Three Months Ended				Nine Months Ended				Three Months Ended
	September 30,				September 30,				March 31,
(in millions)	2022		2021		2022		2021		2023		2022
Net income (loss)	$	(119.8)	$	93.1	$	(65.6)	$	316.2	$	(48.9)	$	16.7
Net income (loss) from discontinued operations		(1.9)		13.7		(1.9)		38.0
Net loss from discontinued operations										—		(0.4)
Net income (loss) from continuing operations		(117.9)		79.4		(63.7)		278.2		(48.9)		17.1
Interest expense, net		30.4		23.0		77.7		56.6		38.3		21.9
Provision for (benefit from) income taxes		(12.1)		5.5		41.4		48.9		(16.7)		22.6
Depreciation and amortization		45.9		49.8		147.1		111.0		56.0		53.0
EBITDA^(a)	$	(53.7)	$	157.7	$	202.5	$	494.7	$	28.7	$	114.6
Net gain on disposition of businesses and assets		—		—		(1.8)		(0.2)		—		(0.3)
Restructuring and other charges^(b)		—		0.2		(1.0)		6.8		3.7		0.4
Acquisition transaction and integration net costs ^(c)		0.4		13.6		6.2		62.8		—		3.2
Acquisition purchase price hedge loss ^(d)		—		—		—		22.0
Asset impairment charges or write-offs^(e)		1.9		1.2		3.9		3.0
European Commission request for information^(f)		—		—		35.6		—
Other items^(g)		14.8		0.7		60.1		7.6
Asset impairment charges or write-offs^(d)										0.3		0.7
European Commission request for information^(e)										—		35.6
Other items^(f)										3.6		23.4
Adjusted EBITDA	$	(36.6)	$	173.4	$	305.5	$	596.7	$	36.3	$	177.6

(a)

EBITDA is a non-GAAP financial performance measure that we refer to in making operating decisions because we believe it provides our management as well as our investors and credit agencies with meaningful information regarding the Company’s operational performance. We believe the use of EBITDA as a metric assists our board of directors, management and investors in comparing our operating performance on a consistent basis. Other companies in our industry may define EBITDA differently than we do. As a result, it may be difficult to use EBITDA, or similarly-named financial measures that other companies may use, to compare the performance of those companies to our performance. We compensate for these limitations by providing reconciliations of our EBITDA results to our net income, which is determined in accordance with GAAP.

Table of Contents

(b)	Amounts for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ primarily relate to charges incurred in connection with the Company’s various restructuring programs. Refer to Note 17 in the condensed consolidated financial statements for further information.

(c)

Amounts for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 ~~and 2021~~ relate to expenses incurred for the Company’s acquisition and integration of the PMMA business and Aristech Surfaces Acquisitions. Refer to Note 3 in the condensed consolidated financial statements for further information.

(d)

Acquisition purchase price hedge loss for the nine months ended September 30, 2021 was due to the change in fair value of the Company’s forward currency hedge arrangement on the euro-denominated purchase price of the PMMA business. Refer to Note 10 in the condensed consolidated financial statements for further information.

~~(e)~~

Amounts for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ primarily relate to the impairment of the Company’s styrene monomer assets in Boehlen, Germany, as described within Note 11 in the condensed consolidated financial statements. ~~There were additional impairment charges of $0.9 million during the three and nine months ended September 30, 2021 recorded on certain long-lived assets in the Base Plastics segment.~~

~~(f)~~(e)

Amount for the ~~nine~~three months ended ~~September 30,~~March 31, 2022 relate to the estimated liability recorded in connection with the European Commission request for information, as described in Note 13 in the condensed consolidated financial statements.

~~Table of Contents~~

~~(g)~~(f)

Other items for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ primarily relate to fees incurred in conjunction with certain of the Company’s strategic initiatives, including the potential divestiture of our styrenics business and our transition to a new enterprise resource planning system.

Liquidity and Capital Resources

Cash Flows

The table below summarizes our primary sources and uses of cash for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022. We have derived the summarized cash flow information from our unaudited financial statements.


	Nine Months Ended				Three Months Ended
	September 30,				March 31,
(in millions)	2022		2021		2023		2022
Net cash provided by (used in):
Operating activities - continuing operations	$	10.8	$	218.7	$	45.4	$	(5.2)
Operating activities - discontinued operations		(1.4)		19.5		—		0.2
Operating activities		9.4		238.2		45.4		(5.0)
Investing activities - continuing operations		(109.0)		(1,885.8)		(21.8)		(46.1)
Investing activities - discontinued operations		(0.8)		(3.3)		—		(0.9)
Investing activities		(109.8)		(1,889.1)		(21.8)		(47.0)
Financing activities		(213.5)		1,272.8		(20.5)		(70.6)
Effect of exchange rates on cash		(16.3)		(3.1)		2.3		(1.7)
Net change in cash, cash equivalents, and restricted cash	$	(330.2)	$	(381.2)	$	5.4	$	(124.3)

Operating Activities

Net cash provided by operating activities from continuing operations during the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 totaled ~~$10.8~~$45.4 million, which included ~~$62.5~~$20.0 million of dividends received from Americas Styrenics. Although operating results ~~were~~continued to be challenged by customer destocking and macroeconomic conditions, ~~resulting~~which resulted in reduced customer demand ~~higher raw material and utility costs~~ and negative earnings, ~~and cash flow,~~ there was a significant working capital release during the quarter. ~~The~~This working capital release ~~which came mostly within the third quarter,~~ was primarily ~~attributable to~~ a ~~steep decline in many raw material prices from the historically high prices seen in the second quarter,~~result of targeted inventory control actions and ~~sequentially lower sales.~~cash improvement initiatives. Net cash used in operating activities from discontinued operations during the ~~nine~~three months ended ~~September 30, 2022 totaled $1.4 million.~~March 31, 2023 was not significant.

Net cash ~~provided by~~used in operating activities from continuing operations during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 totaled ~~$218.7~~$5.2 million. Solid earnings during the period, including $7.5 million ~~driven by strong earnings, and inclusive~~ of dividends received from Americas Styrenics, ~~of $60.0 million. Partially offsetting these factors was~~were more than offset by a ~~$174.7 million reduction in operating cash from net~~significant working capital ~~changes during the period, which were primarily attributable to increases in~~build. This working capital build was driven by significantly increasing raw material ~~costs.~~and utility prices, coupled with a build of inventory ahead of planned turnaround activities. Net cash provided by operating activities from discontinued operations during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 totaled ~~$19.5 million, which was also primarily attributable to raw material cost increases and higher inventory related to discontinued operations.~~$0.2 million.

Table of Contents

Investing Activities

Net cash used in investing activities from continuing operations during the ~~nine~~three months ended ~~September 30,~~March 31, 2023 totaled $21.8 million, which was primarily attributable to capital expenditures. The Company has taken proactive measures to reduce and defer capital expenditures during the year as part of our liquidity improvement actions.

Net cash used in investing activities from continuing operations during the three months ended March 31, 2022 totaled ~~$109.0~~$46.1 million, which was primarily attributable to net cash paid for asset or business acquisitions of $22.2 million (see Note 3), and capital expenditures, including cash spent for our ongoing ~~enterprise resource planning system~~ERP upgrade, of ~~$94.0~~$23.9 million. Net cash used in investing activities from discontinued operations during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 totaled ~~$0.8~~$0.9 million.

Net cash used in investing activities from continuing operations during the nine months ended September 30, 2021 totaled $1,885.8 million, which was primarily attributable to net cash paid for asset or business acquisitions of $1,806.6 million, capital expenditures of $64.7 million, and payments for the settlement of hedging instruments of $14.7 million

~~Table of Contents~~

(related to the acquisition purchase price hedge). Net cash used in investing activities from discontinued operations during the nine months ended September 30, 2021 totaled $3.3 million, which was entirely attributable to capital expenditures.

Financing Activities

Net cash used in financing activities during the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 totaled ~~$213.5~~$20.5 million. This activity was primarily due to ~~$151.9~~$11.8 million of dividends paid, and $6.3 million in debt repayments.

Net cash used in financing activities during the three months ended March 31, 2022 totaled $70.6 million. This activity was primarily due to $51.9 million of payments related to the repurchase of ordinary shares, ~~$36.3~~$12.4 million of dividends paid, and $12.2 million of net repayments of short-term borrowings. In addition, there was $12.9 million of repurchases and repayments of long-term debt during the period, primarily related to our 2024 Term Loan B and 2028 Term Loan B obligations.

Net cash provided by financing activities during the nine months ended September 30, 2021 totaled $1,272.8 million. This activity was primarily due to $746.3 million in proceeds from the issuance of the 2028 Term Loan B, $450.0 million in proceeds from the issuance of the 2029 Senior Notes, $120.0 million in net proceeds from a draw on the Accounts Receivable Securitization Facility, and $10.5 million in proceeds from exercise of option awards. This activity was partially offset by $35.0 million of deferred financing fees primarily related to the issuance of our 2028 Term Loan, $11.6$3.6 million of net repayments of short-term borrowings, ~~$9.5 million of dividend payments,~~ and ~~$7.1~~$3.6 million of net principal payments related to our 2024 Term Loan B and 2028 Term Loan B during the period. This activity was partially offset by $1.7 million in proceeds from the exercise of option awards during the period.

Free Cash Flow

We use Free Cash Flow as a non-GAAP measures to evaluate and discuss the Company’s liquidity position and results. Free Cash Flow is defined as cash from operating activities, less capital expenditures. We believe that Free Cash Flow provides an indicator of the Company’s ongoing ability to generate cash through core operations, as it excludes the cash impacts of various financing transactions as well as cash flows from business combinations that are not considered organic in nature. We also believe that Free Cash Flow provides management and investors with useful analytical indicator of our ability to service our indebtedness, pay dividends (when declared), and meet our ongoing cash obligations.

Free Cash Flow is not intended to represent cash flows from operations as defined by GAAP, and therefore, should not be used as an alternative for that measure. Other companies in our industry may define Free Cash Flow differently than we do. As a result, it may be difficult to use this or similarly-named financial measures that other companies may use, to compare the liquidity and cash generation of those companies to our own. We compensate for these limitations by providing a reconciliation to cash provided by operating activities from continuing operations, which is determined in accordance with GAAP.


	Nine Months Ended				Three Months Ended
	September 30,				March 31,
(in millions)	2022		2021		2023		2022
Cash provided by operating activities	$	9.4	$	238.2
Cash provided by (used in) operating activities					$	45.4	$	(5.0)
Capital expenditures		(94.8)		(68.0)		(21.8)		(24.8)
Free Cash Flow	$	(85.4)	$	170.2	$	23.6	$	(29.8)

Refer to the discussion above for significant impacts to cash provided by operating activities for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022.

Capital Resources and Liquidity

We require cash principally for day-to-day operations, to finance capital investments and other initiatives, to purchase materials, to service our outstanding indebtedness, and to fund the return of capital to shareholders via dividend payments and ordinary share repurchases, when deemed appropriate. Our sources of liquidity include cash on hand, cash flow from operations from continuing operations, and amounts available under the Senior Credit Facility and the Accounts Receivable Securitization Facility (discussed further below).

At September 30, 2022 and December 31, 2021, we had $2,352.8 million and $2,368.8 million, respectively, in outstanding indebtedness and $853.4 million and $1,064.1 million, respectively, in working capital (calculated as current

4539

Table of Contents

~~assets from continuing operations less current liabilities from continuing operations).~~At March 31, 2023 and December 31, 2022, we had $2,350.6 million and $2,353.7 million, respectively, in outstanding indebtedness and $658.5 million and $701.3 million, respectively, in working capital. In addition, as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, we had ~~$242.2~~$123.8 million and ~~$560.6~~$168.7 million, respectively, of foreign cash and cash equivalents on our balance sheet, outside of Ireland, our country of domicile, all of which is readily convertible into other foreign currencies, including the U.S. dollar. Our intention is not to permanently reinvest our foreign cash and cash equivalents. Accordingly, we record deferred income tax liabilities related to the unremitted earnings of our subsidiaries.

The following table outlines our outstanding indebtedness as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 and the associated interest expense, including amortization of deferred financing fees and debt discounts. Effective interest rates for the borrowings included in the table below exclude the impact of deferred financing fee amortization, certain other fees charged to interest expense (such as fees for unused commitment fees during the period), and the impacts of derivatives designated as hedging instruments. For definitions of capitalized terms not included herein, refer to our Annual Report on Form 10-K (“Annual Report”).

��

As of and for the Nine Months Ended

As of and for the Year Ended

September 30, 2022

December 31, 2021

Effective

Effective

Interest

Interest

Interest

Interest

($ in millions)

Balance

Rate

Expense

Balance

Rate

Expense

Senior Credit Facility

2024 Term Loan B

$
665.2

3.1
%
$
18.8

$
670.4

2.1
%
$
20.6

2028 Term Loan B

737.6

3.5
%

22.3

742.8

2.6
%

15.2

2026 Revolving Facility

—

—
%

1.3

—

—
%

2.1

2029 Senior Notes

447.0

5.1
%

18.6

450.0

5.1
%

19.0

2025 Senior Notes

500.0

5.4
%

18.7

500.0

5.4
%

20.7

Accounts Receivable Securitization Facility

—

—
%

1.0

—

2.0
%

1.8

Other indebtedness*

3.0

1.5
%

—

5.6

2.2
%

—

Total

$
2,352.8

$
80.7

$
2,368.8

$
79.4

*For the nine months ended September 30, 2022, interest expense on “Other indebtedness” totaled less than $0.1 million.


	As of and for the Three Months Ended						As of and for the Year Ended
	March 31, 2023						December 31, 2022
			Effective						Effective
			Interest		Interest				Interest		Interest
($ in millions)	Balance		Rate		Expense		Balance		Rate		Expense
Senior Credit Facility
2024 Term Loan B	$	661.7	6.5	%	$	11.6	$	663.4	3.9	%	$	29.1
2028 Term Loan B		734.1	7.0	%		13.8		735.9	4.2	%		34.7
2026 Revolving Facility		—	—	%		0.5		—	—	%		1.8
2029 Senior Notes		447.0	5.1	%		6.3		447.0	5.1	%		24.8
2025 Senior Notes		500.0	5.4	%		7.0		500.0	5.4	%		25.8
Accounts Receivable Securitization Facility		—	—	%		0.3		—	—	%		1.4
Other indebtedness		7.8	5.6	%		0.1		7.4	5.1	%		0.1
Total	$	2,350.6			$	39.6	$	2,353.7			$	117.7

As of ~~September 30, 2022,~~March 31, 2023, our Senior Credit Facility included the 2026 Revolving Facility, which is scheduled to mature in May 2026 and had a borrowing capacity of $375.0 ~~million.~~million and $22.0 million outstanding letters of credit. The 2026 Revolving Facility contains a springing covenant which applies when 30% or more is drawn from the facility. This covenant requires the Company to meet a first lien net leverage ratio (as defined in our secured credit agreement) not to exceed 3.50x at the end of each financial quarter. As of ~~September 30, 2022,~~March 31, 2023, the first lien net leverage ratio was 4.85x, and as such, the Company had ~~$369.2~~$100.5 million of funds available for borrowing (net of ~~$5.8~~$12.0 million outstanding letters of ~~credit) under~~credit as defined in the ~~2026 Revolving Facility.~~secured credit agreement). Further, as of ~~September 30, 2022,~~March 31, 2023, the Company is required to pay a quarterly commitment fee in respect of any unused commitments under the 2026 Revolving Facility equal to 0.375% per annum. The 2026 Revolving Facility contains a springing covenant which applies when 30% or more is drawn from the facility, and would require the Company to meet a first lien net leverage ratio not to exceed 3.5x at the end of each financial quarter. As of September 30, 2022 the first lien net leverage ratio (as defined in our secured credit agreement) was 2.9x.

Also included in our Senior Credit Facility is our 2024 Term Loan B (with original principal of $700.0 million, maturing in September 2024), and our 2028 Term Loan B (with original principal of $750.0 million, maturing in May 2028).

~~Our~~As of March 31, 2023, our 2025 Senior Notes, as issued under the Indenture executed in 2017, include $500.0 million aggregate principal amount of 5.375% senior notes that mature on September 1, 2025.

~~Our~~As of March 31, 2023, our 2029 Senior Notes, as issued under the Indenture executed in 2021, include $447.0 million aggregate principal amount of 5.125% senior notes that mature on April 1, 2029.

We also continue to maintain our Accounts Receivable Securitization Facility, which matures in November 2024 and has an outstanding borrowing capacity of $150.0 million. As of ~~September 30, 2022,~~March 31, 2023, there were no amounts outstanding under this facility and the Company had approximately $150.0 million of accounts receivable available to support this facility, based on the pool of eligible accounts receivable. Refer to Note 8 in the consolidated financial statements for further information on the facility.

Our ability to raise additional financing and our borrowing costs may be impacted by short- and long-term debt

4640

Table of Contents

ratings assigned by independent rating agencies, which are based, in significant part, on our performance as measured by certain credit metrics such as interest coverage and leverage ratios.

We and our subsidiaries, affiliates or significant shareholders may from time to time seek to retire or purchase our outstanding debt through cash purchases in the open market, privately negotiated transactions, exchange transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

Trinseo Materials Operating S.C.A. and Trinseo Materials Finance, Inc. (the “Issuers” of our 2029 Senior Notes and 2025 Senior Notes and “Borrowers” under our Senior Credit Facility) are dependent upon the cash generation and receipt of distributions and dividends or other payments from our subsidiaries and joint venture in order to satisfy their debt obligations. There are no known significant restrictions by third parties on the ability of subsidiaries of the Company to disburse or dividend funds to the Issuers and the Borrowers in order to satisfy these obligations. However, as the Company’s subsidiaries are located in a variety of jurisdictions, the Company can give no assurances that our subsidiaries will not face transfer restrictions in the future due to regulatory or other reasons beyond our control.

The Senior Credit Facility and Indentures also limit the ability of the Borrowers and Issuers, respectively, to pay dividends or make other distributions to Trinseo PLC, which could then be used to make distributions to shareholders. During the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, the Company declared dividends of ~~$0.96~~$0.14 per ordinary share, totaling ~~$35.1~~$5.2 million, all of which ~~$12.4 million~~ was accrued as of ~~September 30, 2022, the majority of which~~March 31, 2023 and was paid in ~~October 2022.~~April 2023. These dividends are well within the available capacity under the terms of the restrictive covenants contained in the Senior Credit Facility and Indentures. Further, additional capacity continues to be available under the terms of these covenants to support expected future dividends to shareholders, should the Company continue to declare them.

~~The Company’s cash flow generation in recent years has been strong.~~ Despite the challenging and uncertain market conditions we are ~~experiencing~~continuing to experience in ~~2022,~~2023, the Company generated positive cash flows from operating activities for the ~~nine~~three months ended ~~September 30, 2022, which we expect~~March 31, 2023 primarily due to ~~continue for full year 2022.~~our cash improvement initiatives and working capital reductions. We believe funds provided by operations, our ~~existing~~ cash and cash equivalent balances of ~~$242.8~~$217.1 million as of March 31, 2023, coupled with borrowings available under our 2026 Revolving Facility and our Accounts Receivable Securitization Facility totaling ~~$519.2~~a minimum of $250.5 million, will be adequate to meet all necessary operating and capital expenditures for at least the next 12 months under the current operating environment, while continuing to ~~invest in~~evolve as a specialty material and sustainable solutions provider. As we weather these trough conditions, the Company maintains access to capital resources and will continue to focus on liquidity improvement actions until customer destocking ends and sales volumes stabilize, at which point we expect our ~~growth and sustainability objectives.~~cash flow generation to resume to normal operating levels.

Further, we also believe that our financial resources will allow us to manage the anticipated impact of this challenging macroeconomic environment on our business operations for the foreseeable future, which could include lower demand, reductions in revenue or delays in payments from customers and other third parties. Our ability to generate cash from operations to pay our indebtedness and meet other liquidity needs is subject to certain risks described herein and under Part I, Item ~~1A-“~~1A – Risk ~~Factors”~~Factors of our Annual Report, as well as ~~the~~ risk factors included in Part II, Item 1A ~~herein~~herein.. As of ~~September 30, 2022,~~March 31, 2023, we were in compliance with all the covenants and default provisions under our debt agreements. Refer to our Annual Report for further information on the details of the covenant requirements.

The ongoing war in Ukraine and the corresponding sanctions and other measures being imposed by various governments have impacted global markets, particularly in Europe, leading to: (i) high volatility and increasing prices for natural gas and other energy supplies, (ii) changing trade flow patterns, and (iii) increasing levels of economic and geopolitical uncertainty globally. We do not have manufacturing operations in Ukraine, Russia or Belarus, and we have temporarily suspended sales and deliveries to Russia and Belarus, which sales do not constitute a material portion of our business. However, a significant escalation or expansion of economic disruption caused by this conflict, including supply disruptions, higher costs of raw materials or energy could have a material adverse effect on our results of operations, financial condition and cash flows. We are actively monitoring the broader economic impact from the crisis, in particular on the price and availability of raw materials and energy.

~~Table of Contents~~

Contractual Obligations and Commercial Commitments

There have been no material revisions outside the ordinary course of business to our contractual obligations as described within “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations and Commercial Commitments” within our Annual Report.

Critical Accounting Policies and Estimates

Our unaudited interim condensed consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenues and expenses at the date of and during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.

Table of Contents

We describe our significant accounting policies in Note 2, Basis of Presentation and Summary of Significant Accounting Policies, in the Notes to Consolidated Financial Statements included in our Annual Report, while we discuss our critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within our Annual Report. There have been no material revisions to the significant accounting policies or critical accounting policies and estimates as filed in our Annual Report.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Recent Accounting Pronouncements

We describe the impact of recent accounting pronouncements in Note 2 of our condensed consolidated financial statements, included elsewhere within this Quarterly Report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As discussed in “Quantitative and Qualitative Disclosures About Market Risk” within our Annual Report, we are exposed to changes in interest rates and foreign currency exchange rates as well as changes in the prices of certain commodities that we use in production. There have been no material changes in our exposure to market risks from the information provided within our Annual Report.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining internal controls designed to provide reasonable assurance that information required to be disclosed by us in our reports that we file or submit under the Exchange Act (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, with the participation of our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of ~~September 30, 2022.~~March 31, 2023. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were effective to provide the reasonable level of assurance described above.

Changes in Internal Control over Financial Reporting

As discussed in Note 3 to the condensed consolidated financial statements, in September 2021, the Company completed the Aristech Surfaces Acquisition. As permitted by the SEC, management elected to exclude this acquisition from its assessment of the effectiveness of its internal control over financial reporting as of December 31, 2021. In September 2022, the Company completed the integration of the Aristech Surfaces business into its internal control

~~Table of Contents~~

~~environment. Otherwise, there~~There were no additional changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the quarter ended ~~September 30, 2022~~March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

From time to time we may be subject to various legal claims and proceedings incidental to the normal conduct of business, relating to such matters as product liability, antitrust, competition, waste disposal practices, release of chemicals into the environment and other matters that may arise in the ordinary course of our business. ~~Other than the European Commission request for information described in Note 13 –~~ ~~Commitments and Contingencies,~~ ~~we currently believe that there is no litigation pending that is likely to have a material adverse effect on our business.~~ Regardless of the outcome, legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. For information regarding new matters and material developments in legal proceedings during the quarter ended ~~September 30, 2022,~~March 31, 2023, see “Litigation Matters” ~~and “European Commission Request for Information”~~ in Note 13 to our condensed consolidated financial statements.

Table of Contents

Item 1A. Risk Factors

Our business faces various risks. Certain important factors may have a material adverse effect on our business prospects, financial condition and results of operations, and you should carefully consider them. Accordingly, in evaluating our business, we encourage you to consider the risk factors related to our ordinary shares as well those risk factors related to our business and industry which have been previously disclosed in Part 1, Item 1A of our Annual Report for the year ended December 31, ~~2021.~~2022. Certain material updates to these risk factors are included below.

We encourage you to consider these risks, in their entirety, in addition to other information contained in or incorporated by reference into this Quarterly Report and our other public filings with the SEC. Other events that we do not currently anticipate or that we currently deem immaterial may also affect our business, prospects, financial condition and results of operations.

~~Risks Related to Our Operations~~

~~Volatility~~We may not be successful in the ~~cost~~proposed divestiture of ~~raw materials, logistics services,~~our styrenics businesses.

In May 2023, we announced our intention to restart the sale of our styrenics business, which had been paused since July 2022, including marketing of individual businesses and sites. While the divestiture of our styrenics businesses remains a key part of our transformation strategy, we cannot estimate whether economic conditions and capital markets will sufficiently improve to allow us to restart and successfully complete a sale of all or ~~transportation utilized for~~a portion of our ~~products,~~styrenics business, or ~~disruption~~guarantee that we will be successful in our efforts to restart the ~~supply~~sale process, generate interest in a sale of all or a portion of the ~~raw materials utilized for~~business, locate an adequate buyer or buyers, or negotiate terms of a sale acceptable to the Company.

A successful divestiture depends on various factors, including our ~~products,~~ability to effectively transfer liabilities, contracts, facilities and employees to any purchaser, revise our legal entity structure, negotiate continued equity ownership, identify and separate intellectual property, reduce fixed costs previously associated with the divested assets or business, and collect the proceeds from any sale. Any divestiture may ~~adversely affect our financial condition and results of operations or cause our financial results to differ materially from our forecasts.~~

~~Our results of operations can be directly affected, positively and negatively, by volatility~~result in the cost of our raw materials, which are subject to global supply and demand and other factors beyond our control. Our principal raw materials (benzene, ethylene, butadiene, BPA, MMA, and styrene) together represent approximately 81% of our total cost of goods sold. Crude oil prices alsoa dilutive impact our raw material and energy costs. Generally, higher crude oil prices lead to higher costs of natural gas and raw materials, although some raw materials are impacted less than others. Volatility in the cost of energy or raw materials makes it more challenging to manage pricing and pass the increases on to our customers in a timely manner. We believe that rapid changes in pricing also can affect the volume our customers consume. As a result, our gross profit and margins could also be adversely affected and our financial results may differ materially from our forecasts.

We are dependent on third-party freight carriers to transport many of our products. Our access to third-party freight carriers is not guaranteed, and we may be unable to transport our products at economically attractive rates in certain circumstances, particularly during disruptions to transportation infrastructure. Our business, financial position, results of operations or cash flows could be materially and adversely affectedfuture earnings if we are unable to ~~pass all~~offset the dilutive impacts from the loss of revenue associated with the ~~cost increases on~~divested business, as well as significant write-offs, including those related to ~~our customers, or if freight carrier capacity in our geographic markets were to decline significantly or otherwise become unavailable.~~

~~We have supply agreements with Dow for ethylene, benzene, butadiene, and MMA, which are critical raw materials to our business. These raw materials~~goodwill and other ~~less critical materials amount to approximately 22% of our total raw materials acquired in 2021, based on aggregate purchase price. The remainder is purchased via other third-party~~

~~Table of Contents~~

suppliers on a global basis. As these and other third-party supply agreements expire, we may be unable to renegotiate or renew these contracts, or obtain new long-term supply agreements on terms comparable or favorable to us, or at all, which may significantly impact our operations. See Part 1, Item 1—Business— Sources and Availability of Raw Materials of our Annual Report for the year ended December 31, 2021 for additional information.

If the availability of any of our principal raw materials is limited, we may be unable to produce some of our products in the quantities demanded by our customers, which could have an adverse effect on plant utilization and our sales of products requiring such raw materials. Suppliers may have temporary limitations preventing them from meeting our requirements, and we may not be able to obtain substitute alternative suppliers in a timely manner or on favorable terms.

~~Continued supply constraints and increases in the cost of energy, including as a result of the ongoing conflict in Ukraine, could adversely impact our results of operations.~~

We use natural gas and electricity to operate our facilities and generate heat and steam for our various manufacturing processes, and these operations can be directly affected by volatility in the cost and availability of energy, which is often subject to factors outside of our control. The ongoing conflict between Russia and Ukraine has impacted global energy markets, particularly in Europe, leading to high volatility and increased prices for natural gas and other energy supplies. Reductions in the supply of natural gas from Russia to Europe has led to ongoing supply shortages in Europe, and European Union member states have recently agreed to a voluntary short-term reduction of natural gas usage as a result of these shortages. Continued natural gas supply shortages, or a shutdown of natural gas supply from Russia, could lead to additional price increases, energy supply rationing, or temporary reduction in operations or closure of our manufacturing plants, which could have a material adverse impact on our business or results of operations.

~~Risks Related to Regulation~~

Trinseo Europe GmbH, one of our subsidiaries, received a Request for Information from the European Commission Directorate General for Competition, involving commercial activity for styrene monomer. To the extent the European Commission’s inquiry would lead to a finding that the Company’s subsidiary violated the law, the results of this finding could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

On June 6, 2018, Trinseo Europe GmbH, a subsidiary of the Company, received a Request for Information in the form of a letter from the European Commission Directorate General for Competition (the “European Commission”) related to styrene monomer commercial activity in the European Economic Area. In addition, the Company commenced an internal investigation into the matter and has discovered instances of inappropriate activity. We have provided all information requested and continue to fully cooperate with the Request for Information.

As a result of further developments in this matter, during the first quarter of 2022, the Company recorded a reserve for an estimated liability of $35.6 million, which remains ongoing and the outcome of which remains unknown. Trinseo Europe GmbH may be subject to fines and/or certain behavioral or structural commitments imposed by the European Commission. If Trinseo Europe GmbH is found to have violated one or more laws, it could also be subject to additional actions by local competition authorities. European Commission inquiries or investigations can continue over a long period of time, which can divert the attention of our management from day-to-day operations and impose significant administrative burdens. Any of these consequences could damage our reputation and impair our ability to conduct business,intangible assets, which could have a material adverse effect on our ~~business, financial condition,~~ results of operations and ~~cash flows.~~financial condition. All of these efforts require varying levels of management resources, which may divert our attention from other business operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a)

Recent sales of unregistered securities

None.

(b)

Use of Proceeds from registered securities

None.

(c)

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

~~Table~~On September 2, 2022, the board of ~~Contents~~

~~The following table contains information regarding purchases~~directors of the Company unanimously approved the authorization of a share repurchase program where the Company may repurchase up to $200.0 million of our ordinary shares, ~~made~~subject to certain parameters defined by the board of directors. The repurchase authorization expires after 18 months and repurchases may be effected through open market purchases, 10b5-1 plans or by other means. There were no share repurchases during the ~~quarter~~three months ended ~~September 30, 2022 by or on behalf~~March 31, 2023. There was $200.0 million remaining for share repurchases as of ~~the Company or any “affiliated purchaser,” as defined by Rule 10b-18(a)(3) of the Securities Exchange Act of 1934:~~

Issuer Purchases of Equity Securities
Period

Total number of shares purchased

Average price
paid per share

Total number of shares purchased as part of publicly announced plans or programs

Approximate number of shares that may yet be purchased under the plans or programs
July 1 - July 31, 2022

1,242,648

$
40.24

1,242,648

—
⁽¹⁾
August 1 - August 31, 2022

—

$
—

—

—
⁽¹⁾
September 1 - September 30, 2022

—

$
—

—

4,970,593
⁽²⁾
Total

1,242,648

$
40.24

1,242,648

~~(1)~~

On December 2, 2021, the board of directors of the Company unanimously approved the authorization of a share repurchase program where the Company may repurchase up to $200.0 million of our ordinary shares, subject to certain parameters defined by the board of directors. Repurchases under this authorization were completed during July 2022 and as such, the plan expired at that time.

~~(2)~~

On September 2, 2022, the board of directors of the Company unanimously approved the authorization of a share repurchase program where the Company may repurchase up to $200.0 million of our ordinary shares, subject to certain parameters defined by the board of directors. The repurchase authorization expires after 18 months and repurchases may be effected through open market purchases, 10b5-1 plans or by other means.

~~Approximate number of shares that may yet be purchased under the plan is calculated using the average price paid per share during the quarter.~~March 31, 2023.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Table of Contents

Item 6. Exhibits

See Exhibit Index.

5144

Table of Contents

EXHIBIT INDEX


Exhibit No.	Description

3.1	Memorandum and Articles of Association of Trinseo PLC, as amended (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed on June 17, 2022).

4.1	Indenture among Trinseo Materials Operating S.C.A., Trinseo Materials Finance, Inc. and The Bank of New York Mellon, as Trustee, dated as of August 29, 2017 (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed September 5, 2017).

4.2	Indenture among Trinseo Materials Operating S.C.A., Trinseo Materials Finance, Inc. and The Bank of New York Mellon, as Trustee, dated as of March 24, 2021 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed March 24, 2021).

10.1*†	Employment Agreement between Trinseo LLC and Paula Cooney, dated October 15, 2021.

10.2*†	Amendment, dated May 9, 2022, to the Employment Agreement between Trinseo LLC and Paula Cooney dated October 15, 2021.

10.3†	Deed of Amendment and Restatement, dated March 31, 2023, entered into by and among Trinseo Europe GmbH, Trinseo Export GmbH, Trinseo Deutschland Anlagengesellschaft mbH, Trinseo Netherlands B.V., Trinseo LLC, Trinseo U.S. Receivables Company SPV LLC, Styron Receivables Funding Designated Activity Company, Trinseo Finance Luxembourg S.à r.l., Luxembourg, Zweigniederlassung Horgen, Regency Assets Designated Activity Company, HSBC Bank plc, Trinseo Holding S.à r.l., TMF Administration Services Limited and the Law Debenture Trust Corporation plc.

31.1†	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2†	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1†	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2†	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS†	XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH†	XBRL Taxonomy Extension Schema Document

101.CAL†	XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF†	XBRL Taxonomy Extension Definition Linkbase Document

101.LAB†	XBRL Taxonomy Extension Label Linkbase Document

101.PRE†	XBRL Taxonomy Extension Presentation Linkbase Document

104†	Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

*Compensatory plan or arrangement.

† Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.

Date: ~~November 4, 2022~~May 5, 2023

	TRINSEO PLC

	By:	/s/ Frank Bozich
	Name:	Frank Bozich
	Title:	President, Chief Executive Officer
		(Principal Executive Officer)

	By:	/s/ David Stasse
	Name:	David Stasse
	Title:	Executive Vice President, Chief Financial Officer
		(Principal Financial Officer)


	January 3,
	2022
Cash and cash equivalents	$	1.0
Other current assets		1.2
Other intangible assets ⁽¹⁾
Customer relationships		5.1
Tradenames		0.9
Developed technology		0.2
Other assets		1.0
Total fair value of assets acquired		9.4

Current liabilities		(1.3)
Noncurrent liabilities		(1.6)
Total fair value of liabilities assumed		(2.9)
Net identifiable assets acquired		6.5
Purchase price consideration		29.3
Goodwill ⁽²⁾	$	22.8

	��
	As of and for the Nine Months Ended						As of and for the Year Ended
	September 30, 2022						December 31, 2021
			Effective						Effective
			Interest		Interest				Interest		Interest
($ in millions)	Balance		Rate		Expense		Balance		Rate		Expense
Senior Credit Facility
2024 Term Loan B	$	665.2	3.1	%	$	18.8	$	670.4	2.1	%	$	20.6
2028 Term Loan B		737.6	3.5	%		22.3		742.8	2.6	%		15.2
2026 Revolving Facility		—	—	%		1.3		—	—	%		2.1
2029 Senior Notes		447.0	5.1	%		18.6		450.0	5.1	%		19.0
2025 Senior Notes		500.0	5.4	%		18.7		500.0	5.4	%		20.7
Accounts Receivable Securitization Facility		—	—	%		1.0		—	2.0	%		1.8
Other indebtedness*		3.0	1.5	%		—		5.6	2.2	%		—
Total	$	2,352.8			$	80.7	$	2,368.8			$	79.4


Issuer Purchases of Equity Securities
Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Approximate number of shares that may yet be purchased under the plans or programs
July 1 - July 31, 2022	1,242,648	$	40.24	1,242,648	—	⁽¹⁾
August 1 - August 31, 2022	—	$	—	—	—	⁽¹⁾
September 1 - September 30, 2022	—	$	—	—	4,970,593	⁽²⁾
Total	1,242,648	$	40.24	1,242,648